Instant Ebooks Textbook Osteoarthritis 2nd Edition Kenneth D. Brandt Download All Chapters
Instant Ebooks Textbook Osteoarthritis 2nd Edition Kenneth D. Brandt Download All Chapters
com
https://ebookname.com/product/osteoarthritis-2nd-edition-
kenneth-d-brandt/
OR CLICK BUTTON
DOWLOAD NOW
https://ebookname.com/product/effective-teacher-hiring-kenneth-d-
peterson/
https://ebookname.com/product/effective-instructional-
strategies-4th-edition-kenneth-d-moore/
https://ebookname.com/product/progress-in-inorganic-
chemistry-1st-edition-kenneth-d-karlin/
https://ebookname.com/product/noise-and-vibration-analysis-
signal-analysis-and-experimental-procedures-2nd-edition-anders-
brandt/
Fat Facts Osteoarthritis second edition Fast Facts
Philip Conaghan
https://ebookname.com/product/fat-facts-osteoarthritis-second-
edition-fast-facts-philip-conaghan/
https://ebookname.com/product/advances-in-cancer-research-
volume-127-1st-edition-kenneth-d-tew/
https://ebookname.com/product/osteoarthritis-a-companion-to-
rheumatology-1st-edition-leena-sharma-md/
https://ebookname.com/product/brittle-matrix-composites-10-1st-
edition-andrzej-brandt/
https://ebookname.com/product/social-psychology-2nd-edition-
kenneth-s-bordens/
Osteoarthritis
Second edition
Edited by
Kenneth D. Brandt
Rheumatology Division, Department of Medicine, and Department of Orthopaedic Surgery
Indiana University School of Medicine
USA
Michael Doherty
Nottingham University Medical School
Nottingham
UK
L. Stefan Lohmander
University Hospital
Lund
Sweden
1
1
Great Clarendon Street, Oxford
Oxford University Press is a department of the University of Oxford.
It furthers the University’s objective of excellence in research, scholarship,
and education by publishing worldwide in
Oxford New York
Auckland Bangkok Buenos Aires Cape Town Chennai
Dar es Salaam Delhi Hong Kong Istanbul Karachi Kolkata
Kuala Lumpur Madrid Melbourne Mexico City Mumbai Nairobi
São Paulo Shanghai Taipei Tokyo Toronto
Oxford is a registered trade mark of Oxford University Press
in the UK and in certain other countries
Published in the United States
by Oxford University Press Inc., New York
© Oxford University Press, 2003
The moral rights of the author have been asserted
Database right Oxford University Press (maker)
First edition Published 1998
Reprinted 2000
Second edition published 2003
All rights reserved. No part of this publication may be reproduced,
stored in a retrieval system, or transmitted, in any form or by any means,
without the prior permission in writing of Oxford University Press,
or as expressly permitted by law, or under terms agreed with the appropriate
reprographics rights organization. Enquiries concerning reproduction
outside the scope of the above should be sent to the Rights Department,
Oxford University Press, at the address above
You must not circulate this book in any other binding or cover
and you must impose this same condition on any acquirer
British Library Cataloguing in Publication Data
Data available
Library of Congress Cataloging in Publication Data
ISBN 0 19 850967 7 (Hbk.)
10 9 8 7 6 5 4 3 2 1
Typeset in Minion
by Newgen Imaging Systems (P) Ltd., Chennai, India
Printed in Hong Kong
Acknowledgements
The efficient and highly competent secretarial support that the editors editors and representatives of the Oxford University Press and, particularly,
received from Joanna Ramowski in Nottingham and Viveca Wiklund in Lund her help in proofing and editing, make this book much better than it would
is hugely appreciated; without their efforts this book would not have seen the have been otherwise. Furthermore, without her diplomacy in reeling in chap-
light of day. In Indianapolis, as usual, Deborah Jenkins provided excellent sec- ters that seemed to be in limbo, we could not have met our deadline.
retarial support. In addition, as was the case when we put together the 1st edi- Finally, we are grateful to Pharmacia for their generous support, which
tion of this book, the initiative, enthusiasm, and dedication to the task shown helped defray production costs for the 2nd edition and, in particular, per-
by Kathie Lane was exemplary. Her professionalism in working with the mitted the use of colour throughout the book.
This page intentionally left blank
Preface
A number of exciting new developments make it highly desirable at this the pathogenesis of OA. The importance of bone in the pathogenesis of OA
time to summarize the large body of knowledge related to the etiopatho- is reflected by the fact that three chapters are now devoted to this topic.
genesis and management of osteoarthritis. For years, many primary care Whereas discussion of hereditary OA was covered in a single chapter in the
physicians and, indeed, many rheumatologists have considered osteoarthri- 1st edition, three chapters are now devoted to genetic aspects of OA. The
tis to be a boring condition for which they had little to offer patients. chapter on synovial physiology has also been wholly rewritten.
Osteoarthritis has been viewed by physicians and surgeons, erroneously, as The section of the book dealing with therapy continues to reflect the
an inevitable consequence of aging or repetitive usage of a joint and a con- recognition that optimal management of OA requires a comprehensive
dition which, once it becomes symptomatic, progresses inexorably. Doctors program involving both pharmacologic agents and nonmedicinal measures
and allied health professionals have conveyed these misconceptions and and, in some cases, surgery. It is the belief of the editors that it remains
oversimplifications to millions of patients. Consider the nihilism, pes- necessary to dispel the widely held notion that medical management is
simism and futility engendered in those patients by such remarks! ‘conservative’ while surgery is ‘radical’ therapy, whereas the opposite is
But things are changing—and changing rapidly. Our understanding of often true—i.e., withholding surgery from patients with advanced disease
mechanisms underlying the breakdown of articular cartilage in osteoarthri- while they become increasingly deconditioned is, in fact, the radical
tis has grown greatly in the past several years—perhaps to an even greater approach; in such instances it may be much more conservative to operate.
extent than our awareness that osteoarthritis is not a disease simply of car- A recent analysis of outcomes of patients undergoing total hip and total
tilage, but of an organ, the diarthrodial joint. Osteoarthritis represents fail- knee arthroplasty supports that view.
ure of the joint. It may be due in some instances to a primary abnormality As indicated in the 1st edition, studies of animal models have shown that
in the articular cartilage, but in other cases the initial problem resides in the the development and progression of OA may be prevented or retarded with
underlying bone, the synovium, the supporting ligaments or the neuro- pharmacologic or biologic agents. The past few years have witnessed
muscular system. further progress in the development of disease-modifying drugs for
The above two paragraphs are quotations from the Preface to the 1st edi- osteoarthritis (DMOADs). Clinical trials of such therapy have already been
tion of Osteoarthritis. And how rapidly things continue to change! For undertaken in humans. A new chapter is devoted to the possible role of
example, the 4 year interval between the publication of the 1st edition and nutraceuticals, such as glucosamine and chondroitin sulfate, in modifica-
the 2nd has witnessed the important development of cyclooxygenase-2 tion of structural damage in the OA joint. The outcome measures available
selective inhibitors, such as celecoxib and rofecoxib, which are now used for assessment of a DMOAD effect in clinical trials, and limitations thereof,
widely in management of osteoarthritis (OA). The new chapter on non- are also discussed.
steroidal anti-inflammatory drugs (NSAIDs) in the 2nd edition discusses The numerous changes that have been made in the 2nd edition of
this topic in considerable detail. The juxtaposed chapter on economic con- Osteoarthritis reflect the rapid, broad, exciting progress which has occurred
siderations in pharmacologic management of OA has also been entirely in the past few years. The new topics and changes in authorship, providing
rewritten. Both chapters have new authors. expertise in the new areas of discussion, reflect those changes. For the edi-
Another important therapeutic development in the interval between the tors, these changes have assured that their work on this book has been both
1st and 2nd editions is intra-articular hyaluronan therapy. The true efficacy educational and fun.
of this treatment with respect to relief of joint pain and modification of The primary care physician, clinical rheumatologist, orthopaedic sur-
structural damage in the OA joint has generated sufficient heat and con- geon, allied health professional, basic researcher, those in the pharmaceuti-
troversy that an entire chapter is now devoted to this topic. Given that cal industry who are involved in development of drugs and biologicals for
results of sham-controlled clinical trials of joint irrigation are now avail- osteoarthritis, and regulatory agency staff should all find this book useful.
able, a chapter also on this form of intra-articular therapy is now included. The high prevalence of OA—which will continue to increase because of the
The 2nd edition differs from the 1st also in a number of other significant aging of the population—guarantees that health professionals will see a
respects: The chapters on physical therapy and occupational therapy have growing number of patients with OA. The need for a timely review of the
been rewritten, with new authorship for both. Chapters have also been evidence that drives our current understanding of optimal management of
added on exercise in management of OA; weight loss and patient adher- OA and of the basic mechanisms involved in its etiopathogenesis serves as
ence. The section of the book dealing with the pathogenesis of OA has been the rationale for the 2nd edition, whose authors continue to represent
updated considerably, in the light of new knowledge: chapters have been experts on OA from both sides of the Atlantic.
added which discuss protective muscular reflexes; proprioception; the
importance of local mechanical factors, such as joint laxity and malalign- Kenneth D. Brandt March 2003
ment; peripheral and central mechanisms relating to the pathogenesis of Michael Doherty
OA pain; and the possible role of vitamin deficiencies and antioxidants in L. Stefan Lohmander
This page intentionally left blank
Contents
9.6 Topical Capsaicin Cream 273 11.2.2 The clinical perspective 401
9.7 Intra-articular glucocorticoids and other injection 11.3 Advantages and limitations of animal models
therapies 277 in the discovery and evaluation of novel disease-
modifying osteoarthritis drugs (DMOADs) 411
9.8 Intra-artiuclar hyaluronan injection 283
11.4 Assessment of changes in joint tissues in patients
9.9 Nutritional therapies 289 treated with disease modifying osteoarthritis
9.10 Mechanisms by which micronutrients may drugs (DMOADs): monitoring outcomes 417
influence osteoarthritis 293 11.4.1 Radiographic grading systems 417
9.11 Physical therapy 299 11.4.2 Quantitation of radiographic changes 426
9.11.1 Exercise for the patient with osteoarthritis 299 11.4.3 Magnetic resonance imaging 433
9.11.2 Other physical therapies 305 11.4.4 Arthroscopic evaluation of knee articular
9.12 Occupational therapy for the patient with cartilage 451
osteoarthritis 311 11.4.5 Bone scintigraphy 456
9.13 Patient education 321 11.4.6 Ultrasonography 462
11.4.7 Defining and validating the clinical role of
9.14 Social support 327
molecular markers in osteoarthritis 468
9.15 Depression in osteoarthritis 333
9.16 Coping strategies for the patient with 12 Design of clinical trials for
osteoarthritis 339 evaluation of structure modifying
9.17 Irrigation of the osteoarthritic joint 347 drugs and new agents for
9.18 Surgical approaches to preserving and restoring symptomatic treatment of
articular cartilage 353 osteoarthritis 479
9.19 Arthroplasty and its complications 361
9.20 Weight loss and osteoarthritis 371 Appendices 489
9.21 Patient adherence 375 A1 The American College of Rheumatology (ACR)
criteria for the classification and reporting of
10 Outcome assessment in osteoarthritis 491
osteoarthritis: a guide for research A2 Lequesne’s algofunctional lower limb indices 493
and clinical practice 381 A3 WOMAC osteoarthritis Index 495
A4 Protocols for radiography 497
11 Prospects for pharmacological
modification of joint breakdown in Index 501
osteoarthritis 391
11.1 Pharmacological modification of joint breakdown
in OA: Do we need it, can we do it, can we prove
it, is it good? 393
List of Contributors
Abramson, Steven B.; New York University School of Medicine, Hospital for Joint Griffiths, R.J.; Inflammation Biology, Pfizer Global Research and Development,
Diseases, New York, NY, USA Groton, CT, USA
Anis, Aslam H.; Centre for Health Evaluation and Outcome Sciences, St. Paul’s Grodzinsky, Alan J.; Departments of Electrical and Mechanical Engineering and
Hospital, Vancouver, BC, Canada Biological Engineering Division, Massachusetts Institute of Technology,
Ang, Dennis C.; Rheumatology Division, Indiana University School of Medicine Cambridge, MA, USA
Indianopolis, IN, USA Hadler, Nortin M.; Department of Medicine, University of North Carolina at
Aspnes, Ann; Department of Psychiatry and Behavioral Sciences, Duke Chapel Hill School of Medicine, Chapel Hill, NC, USA
University Medical Center, Durham, NC, USA Hart, Deborah J.; Department of Rheumatology, St. Thomas’ Hospital, London,
Ayral, Xavier; Department of Rheumatology, Cochin Hospital, René Descartes UK
University, Paris, France Hassett, Geraldine; Department of Rheumatology, St. Thomas’ Hospital,
Barlow, Julie; The Interdisciplinary Research Centre in Health, Coventry London, UK
University, Coventry, UK Heinegard, Dick; Department of Cell and Molecular Biology, University of Lund,
Bayliss, Michael; Department of Veterinary Basic Sciences, The Royal Veterinary Lund, Sweden
College, London, UK Hochberg, Marc; Departments of Medicine and Epidemiology and Preventive
Bellamy, Nicholas; CONROD, Faculty of Health Sciences, University of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
Queensland, Queensland, Australia Hurley, Michael V.; Rehabilitation Research Unit, Physiotherapy Division, King’s
Bischoff, Heike A.; Department of Medicine, Harvard Medical School, Brigham College London, London, UK
& Women’s Hospital, Boston, MA, USA Hung, Clark T.; Department of Biomedical Engineering, Columbia University,
Bradley, John D.; Rheumatology Division, Indiana University School of New York, NY, USA
Medicine, and Wishard Memorial Hospital, Indianapolis, IN, USA Hunziker, Ernst B.; ITI Research Institute, University of Bern, Switzerland
Brandt, Kenneth D.; Rheumatology Division, Department of Medicine, and Ingvarsson, Thorvaldur; Akureyri University Hospital, Akureyri, Iceland
Department of Orthopaedic Surgery, Indiana University School of Jones, Adrian; Rheumatology Unit, Nottingham City Hospital, Nottingham, UK
Medicine, Indianapolis, IN, USA
Kashikar-Zuck, Susmita; Department of Psychiatry and Behavioral Sciences,
Buckland-Wright, J. Christopher; University of London, Applied Clinical Duke University Medical Center, Durham, NC, USA
Anatomy Research Centre, King’s College London, School of Biomedical
Keefe, Francis J.; Department of Psychiatry and Behavioral Sciences, Duke
Sciences, London, UK
University Medical Center, Durham, NC, USA
Buckwalter, Joseph A.; Department of Orthopaedic Surgery, University of Iowa
Kidd, Bruce; Bone and Joint Research Unit, St. Barts and the Royal London
Hospitals, Iowa city, IA, USA
School of Medicine and Dentistry, London, UK
Burr, David B.; Department of Anatomy and Cell Biology, Indiana University
Kim, Young-Jo; Children’s Hospital, Harvard Medical School, Boston, MA, USA
School of Medicine, Indianapolis, IN, USA
Knutson, Kaj; Department of Orthopaedics, University Hospital, Lund, Sweden
Caldwell, David S.; Division of Rheumatology and Immunology, Department of
Medicine, Duke University Medical Center, Durham, NC, USA Kraus, Virginia Byers; Department of Medicine, Division of Rheumatology,
Carr, Alison; Academic Rheumatology, University of Nottingham, Nottingham, UK Duke University Medical Center, Durham, NC, USA
Cibere, Jolanda; Arthritis Research Centre of Canada, Vancouver, BC, Canada Kroenke, Kurt; Regenstrief Institute for Health Care, Indianapolis, IN, USA
Cooper, Cyrus; MRC Environmental Epidemiology Unit, Southampton General Liang, H. Mathew; Department of Medicine, Harvard Medical School, Brigham
Hospital, University of Southampton, Southampton, UK & Women’s Hospital, Boston, MA, USA
Dennison, Elaine; MRC Environmental Epidemiology Unit, Southampton Lohmander, L. Stefan; Department of Orthopedics, University Hospital, Lund,
General Hospital, University of Southampton, Southampton, UK Sweden
Dieppe, Paul MRC Health Services Research Collaboration, University of Lorenzo, Pilar; Department of Cell and Molecular Biology, University of Lund,
Bristol, Bristol, UK Lund, Sweden
DiMicco, Michael A.; Centre for Biomedical Engineering, Massachusetts institute Lorig, Kate; Stanford University, Palo Alto, CA, USA
of Technology, and Children’s Hospital, Harvard Medical School, Cambridge, Manek, Nisha; Twin Research and Genetic Epidemiology Unit, St. Thomas’
MA, USA Hospital, London, UK
Doherty, Michael; Academic Rheumatology, Nottingham City Hospital, Marra, Carlo A.; Centre for Health Evaluation and Outcome Sciences, St. Paul’s
Nottingham, UK Hospital, Vancouver, BC, Canada
Felson, David; Boston University Arthritis Center and the Department of Martin, Eden R.; Department of Medicine, Section of Medical Genetics, Duke
Medicine at Boston City and Boston University Medical Center Hospital, University Medical Center, Durham, NC, USA
Boston, MA, USA Mazucca, Steven A.; Rheumatology Division, Indiana University School of
Flores, Raymond; Department of Medicine, University of Maryland School of Medicine, Indianapolis, IN, USA
Medicine, Baltimore, MD, USA McAlindon, Timothy E.; Boston University School of Medicine, Boston, MA, USA
Ghosh, Peter; Institute of bone and joint research, Royal North Shore Hospital, Melvin, Jeanne L.; Chronic Pain and Fibromyalgia Management Programs,
St Leonards, NSW, Australia Cedars-Sinai Medical Center, Los Angeles, CA, USA
xii
Minor, Marian A.; Department of Physical Therapy, School of Health Schrier, D.J.; Inflammation Pharmacology, Pfizer Global Research and
Professions, University of Missouri, Columbia, MO, USA Development, Ann Arbor, MI, USA
Mow, Van C.; Department of Biomedical Engineering and New York Orthopaedic Schauwecker, Donald S.; Department of Radiology, Indiana University School of
Hospital Research Laboratory, Columbia University, New York, NY, USA Medicine, Indianapolis, IN, USA
Myers, Stephen L.; Eli Lilly and Company, Indianapolis, IN, USA Sharma, Leena; Division of Rheumatology, Northwestern University Medical
Muir, Kenneth R.; Department of Public Health Medicine and Epidemiology, School, Chicago, IL, USA
Queen’s Medical Center, Nottingham, UK Simkin, Peter A.; Division of Rheumatology, University of Washington, Seattle,
O’Connor, Brian L.; Indiana University School of Medicine, Indianapolis, IN, WA, USA
USA Spector, Tim D.; Twin Research and Genetic Epidemiology Unit, St Thomas’
O’Reilly, Sheila; Rheumatology Unit, Nottingham City Hospital, Nottingham, UK Hospital, London, UK
Peterfy, Charles G.; Synarc, San Francisco, CA, USA Stefansson, Stefan Einar; deCODE, Reykjavik, Iceland
Plaas, Anna H.K.; Biochemistry and Molecular Biology, University of South Tyler, Jenny; Strangeways Research Laboratory, Cambridge, UK
Florida, and Center for Research in Paediatric Orthopaedics, Shriners van Beuningen, Henk M.; University Medical Centre Nijmegen, Nijmegen, the
Hospital, Tampa, FL, USA Netherlands
Poole, A. Robin; Joint Diseases Laboratory and Department of Surgery, Shriner’s van der Kraan, Peter M.; University Medical Centre Nijmegen, Nijmegen, the
Hospital for Crippled Children, Montreal, Quebec, Canada Netherlands
Pritzker, Kenneth P.H.; Pathology and Laboratory Medicine, Mount Sinai van den Berg, Wim B.; University Medical Centre Nijmegen, Nijmegen, the
Hospital, Toronto, Ontario, Canada and University of Toronto, Canada Netherlands
Reid, David M.; Department of Medicine and Therapeutics, University of Vilensky, Joel A.; Indiana University School of Medicine, Fort Wayne, IN, USA
Aberdeen, Aberdeen, UK Walsh, Nicola; Rehabilitation Research Unit, Physiotherapy Division, King’s
Rogers, Juliet; Bristol Royal Infirmary, Bristol, UK (deceased) College London, London, UK
Roos, Ewa M.; Department of Orthopedics, University Hospital, Lund, Sweden Watt, Iain; Directorate of Clinical Radiology, Bristol Royal Infirmary, Bristol, UK
Rosenthal, Ann K.; Division of Rheumatology, Department of Medicine, Medical Webber, Jonathan; Clinical Nutrition Unit, Queen’s Medical Center, Nottingham,
College of Wisconsin, and the Zablocki Veterans Administration Medical UK
Center, Milwaukee, WI, USA Westacott, C.I.; Department of Pathology and Microbiology, University of
Ryan, Lawrence M.; Division of Rheumatology, Department of Medicine, Bristol, School of Medical Sciences, University Walk, Bristol, UK
Medical College of Wisconsin, Milwaukee, WI, USA Weinberger, Morris; Department of Health Policy and Administration,
Sandy, John D.; Department of Pharmacology and Therapeutics, University of University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
South Florida, and Senior Scientist, Center for Research in Skeletal Yelin, Edward; Arthritis Research Group, University of California, San Francisco,
Development and Pediatric Orthopedics, Shriners Hospital, Tampa, FL, USA CA, USA
1 Definition and classification of
osteoarthritis
Raymond H. Flores and Marc C. Hochberg
Osteoarthritis (OA), formerly referred to as osteoarthrosis and degenerative capsule, synovial membrane, and periarticular muscles. Ultimately, the
joint disease, is the most common form of arthritis.1,2 Prior to 1986, no articular cartilage degenerates with fibrillation, fissures, ulceration, and
standard definition of OA existed; most authors described OA as a disorder full thickness loss of the joint surface. … OA diseases are a result of both
of unknown etiology that primarily affects the articular cartilage and sub- mechanical and biologic events that destabilize the normal coupling of
chondral bone in contrast to rheumatoid arthritis, a disorder that primar- degradation and synthesis of articular cartilage chondrocytes and extra-
ily affects the synovial membrane. In that year, the Subcommittee on cellular matrix, and subchondral bone. Although they may be initiated
Osteoarthritis of the American College of Rheumatology Diagnostic and by multiple factors, including genetic, developmental, metabolic, and
Therapeutic Criteria Committee, proposed the following definition of OA: traumatic, OA diseases involve all of the tissues of the diarthrodial joint.
a heterogeneous group of conditions that lead to joint symptoms and signs Ultimately, OA diseases are manifested by morphologic, biochemical,
which are associated with the defective integrity of articular cartilage, in molecular, and biomechanical changes of both cells and matrix which
addition to related changes in the underlying bone at the joint margins.3 lead to a softening, fibrillation, ulceration, loss of articular cartilage, scler-
A more comprehensive definition of OA was developed at the ‘Workshop osis and eburnation of subchondral bone, osteophytes, and subchondral
on Etiopathogenesis of Osteoarthritis’ sponsored by the National Institute cysts. When clinically evident, OA diseases are characterized by joint
of Arthritis, Diabetes, Digestive, and Kidney Diseases, the National Institute pain, tenderness, limitation of movement, crepitus, occasional effusion,
on Aging, the American Academy of Orthopedic Surgeons, the National and variable degrees of inflammation without systemic effects.
Arthritis Advisory Board, and the Arthritis Foundation.4 This definition
summarized the clinical, pathophysiologic, biochemical, and biomechanical
changes that characterize OA:
Classification of osteoarthritis
Clinically, the disease is characterized by joint pain, tenderness, limitation
of movement, crepitus, occasional effusion, and variable degrees of local OA, as noted above, is a disorder of diverse etiologies, which affects both
inflammation, but without systemic effects. Pathologically, the disease is the small and large joints, either singly or in combination. Table 1.1 con-
characterized by irregularly distributed loss of cartilage more frequently tains a classification schema for OA developed at the ‘Workshop on
in areas of increased load, sclerosis of subchondral bone, subchondral Etiopathogenesis of Osteoarthritis’4 in which idiopathic OA is divided into
cysts, marginal osteophytes, increased metaphyseal blood flow, and vari- two forms: localized or generalized; the latter represents the form of OA
able synovial inflammation. Histologically, the disease is characterized described by Kellgren and Moore involving three or more joint groups.6
early by fragmentation of the cartilage surface, cloning of chondrocytes, Furthermore, generalized OA may occur with or without Heberden’s and
vertical clefts in the cartilage, variable crystal deposition, remodeling, and Bouchard’s nodes, that is as either a nodal or non-nodal form.
eventual violation of the tidemark by blood vessels. It is also characterized The classification of OA into idiopathic (primary) and secondary forms
by evidence of repair, particularly in osteophytes, and later by total loss of was based on the knowledge that OA could result from some recognized
cartilage, sclerosis, and focal osteonecrosis of the subchondral bone. causative factors. These factors operate largely through two mechanisms:
Biomechanically, the disease is characterized by alteration of the tensile, abnormalities of the biomaterials of the joint, usually the articular cartilage;
compressive, and shear properties and hydraulic permeability of the and abnormalities of the biomechanics of the joint, usually due to the
cartilage, increased water, and excessive swelling. These cartilage changes abnormal joint structure, resulting in abnormalities in the distribution of
are accompanied by increased stiffness of the subchondral bone. loading forces across the joint. Thus, patients with an underlying disease
Biochemically, the disease is characterized by reduction in the proteo- that appears to have caused their OA are classified as having secondary OA.
glycan concentration, possible alterations in the size and aggregation of A detailed discussion of several forms of secondary OA can be found else-
proteoglycans, alteration in collagen fibril size and weave, and increased where.7 While this classification is helpful for teaching and research pur-
synthesis and degradation of matrix macromolecules. poses, it has obvious deficiencies as some risk factors for idiopathic OA, for
example obesity, may be considered, alternatively, as causes of secondary
The current definition was developed in 1994 at a workshop entitled OA (see Chapter 2).
‘New Horizons in Osteoarthritis’ sponsored by the American Academy of
Orthopedic Surgeons, the National Institute of Arthritis, Musculoskeletal
and Skin Diseases, the National Institute on Aging, the Arthritis
Foundation, and the Orthopaedic Research and Education Foundation.5
Diagnostic criteria for osteoarthritis
This definition underscores the concept that OA may not represent a single Radiographic criteria
disease entity:
Classically, the diagnosis of OA in epidemiological studies has relied on the
Osteoarthritis is a group of overlapping distinct diseases, which may have characteristic radiographic changes described by Kellgren and Lawrence in
different etiologies but with similar biologic, morphologic, and clinical 19578 and illustrated in the Atlas of Standard Radiographs.9 The cardinal
outcomes. The disease processes not only affect the articular cartilage, radiographic features of OA include: (1) the formation of osteophytes
but involve the entire joint, including the subchondral bone, ligaments, on the joint margins or in ligamentous attachments, as on the tibial spines;
2 1
Table 1.1 Classification of osteoarthritis* (2) the periarticular ossicles, chiefly in relation to distal and proximal inter-
phalangeal joints; (3) the narrowing of the joint space associated with scler-
I Idiopathic osis of subchondral bone; (4) the cystic areas with sclerotic walls situated in
A Localized the subchondral bone; and (5) the altered shape of the bone ends, particu-
1 Hands: e.g. Heberden’s and Bouchard’s nodes (nodal), erosive larly the head of the femur. Combinations of these changes considered
interphalangeal arthritis (non-nodal), carpal-1st metacarpal together led the authors to the development of an ordinal grading scheme
2 Feet: e.g. hallux valgus, hallux rigidus, contracted toes for severity of radiographic features of OA: 0 normal; 1 doubtful;
(hammer/cock-up toes), talonavicular 2 minimal; 3 moderate; and 4 severe. Different joints are graded
using different characteristics. For the small joints of the hands, knees, and
3 Knee: (a) medial compartment; (b) lateral compartment;
(c) patello-femoral compartment
hips these differences are summarized in Tables 1.2–1.4 and illustrated in
Figs. 1.1–1.5, respectively.
4 Hip: (a) eccentric (superior); (b) concentric (axial, medial);
A number of potential limitations of the use of the Kellgren–Lawrence
(c) diffuse (coxae senilis)
grading scale, as illustrated in the Atlas on Standard Radiographs, have been
5 Spine: (a) apophyseal joints; (b) intervertebral joints (discs); noted.10–13 Foremost among these is the fact that the radiographs of nei-
(c) spondylosis (osteophytes); (d) ligamentous (hyperostosis, ther the hips nor knees were taken in the weight-bearing position, limiting
Forestier’s disease, DISH) the ability of the reader to accurately assess joint-space narrowing as a meas-
6 Other single sites: e.g. glenohumeral, acromioclavicular, tibiotalar, ure of cartilage loss. In an attempt to address the limitations of a global
sacroiliac, temporomandibular grading scale, several groups developed radiographic grading schema that
B Generalized (GOA) includes three or more areas above (6) focus on the individual radiographic features of OA at specific joint groups;
II Secondary reliable grading scales have been published for the hand,14 hip,15,16
knee,17–20 and for all three of these peripheral joint groups.21,22 The atlas
A Trauma
1 Acute
Table 1.2 Grades of severity of osteoarthritis in the small joints of
2 Chronic (occupational, sports)
the hands*
B Congenital or developmental diseases
1 Localized diseases: e.g. Legg–Calve–Perthes, congenital hip Distal interphalangeal joints:
dislocation, slipped epiphysis Grade 1 Normal joint except for one minimal osteophyte
2 Mechanical factors: e.g. unequal lower extremity length, Grade 2 Definite osteophytes at two points with minimal subchondral
valgus/varus deformity, hypermobility syndromes sclerosis and doubtful subchondral cysts, but good joint space
3 Bone dysplasias: e.g. epiphyseal dysplasia, spondyloapophyseal and no deformity
dysplasia, osteonychondystrophy Grade 3 Moderate osteophytes, some deformity of bone ends and
C Metabolic diseases narrowing of joint space
1 Ochronosis (alkaptonuria) Grade 4 Large osteophytes and deformity of bone ends with loss of joint
2 Hemochromatosis space, sclerosis, and cysts
* Reproduced from Ref. 4 with permission. * Taken from Ref. 9. Reproduced from Silman, A.J., Hochberg, M.C. (1993). Epidemiology
of the Rheumatic Diseases. Oxford: Oxford University Press.
1 3
* Taken from Ref. 9. Reproduced from Silman, A.J., Hochberg, M.C. (1993). Epidemiology
of the Rheumatic Diseases. Oxford: Oxford University Press.
(a) (b)
(c) (d)
(c) (d)
(a) (b)
(c) (d)
Fig. 1.3 Grades of severity of OA of the first carpometacarpal joint: (a) Grade 1; (b) Grade 2; (c) Grade 3; (d) Grade 4.
Source: Reproduced from Silman, A.J. and Hochberg, M.C. (1993). Epidemiology of the Rheumatic Diseases. Oxford: Oxford University Press.
(a) (b)
(c) (d)
Fig. 1.4 Grades of severity of OA of the knee: (a) Grade 1; (b) Grade 2; (c) Grade 3; (d) Grade 4.
Source: Reproduced from Silman, A.J. and Hochberg, M.C. (1993). Epidemiology of the Rheumatic Diseases. Oxford: Oxford University Press.
1 5
Table 1.5 Radiographic features of osteoarthritis illustrated in the measured in millimeters; in addition, an overall qualitative grade of 3 or
Atlas of the Osteoarthritis Research Society International* higher (Table 1.6) was strongly associated with reported hip pain. These
findings were subsequently confirmed by Scott et al. in an analysis of
Joint group and feature Range of grades data from women aged 65 and older, who had pelvic radiographs obtained
Hand at entry into the ‘Study of Osteoporotic Fractures’, a longitudinal epidemi-
Marginal osteophytes 0–3
ologic study of risk factors for osteoporotic fractures.26 In a more recent
study, Ingvarsson and colleagues compared the reliability of measuring
Joint-space narrowing 0–3
minimum joint space with the Kellgren–Lawrence global scale for assessing
Subchondral sclerosis 0–3 the prevalence of hip OA using colon radiographs in Iceland.27 They noted
Subchondral erosions 0–3 that the measurement of the minimum joint space had better intra-observer
Malalignment 0–3 and inter-observer reliability than the global grade, although prevalence
estimates were similar between the two methods. Based on the validity of
Hip
the association of individual radiographic features with hip pain, and the
Marginal osteophytes 0–3 greater reliability of scoring individual features, as compared to the global
Joint-space narrowing 0–3 Kellgren–Lawrence score,15,16,27 future population-based epidemiological
Subchondral sclerosis 0–3 studies of OA of the hip should rely on the presence of individual radio-
Subchondral lucencies 0–3 graphic features and the Croft or modified Croft global scales, rather
than on the Kellgren–Lawrence grading scale, for classifying cases of OA of
Femoral buttressing 0–3
the hip.28
Knee (Tibiofemoral joint) Spector et al. examined the association of the individual radiographic
Marginal osteophytes 0–3 features of knee OA with reported knee pain in 977 women aged 45–
Joint-space narrowing 0–3 64 years who were participants in the Chingford Study, a longitudinal study
Subchondral sclerosis 0–3
Table 1.6 Croft’s overall qualitative grading of hip OA*
Subchondral erosions 0–3
Malalignment 0–3 Grade Definition
Attrition 0–3 0 No changes of osteoarthritis
Tibial spine hypertrophy 0–1 1 Osteophytosis only
Knee (Patellofemoral joint) 2 Joint-space narrowing only
Marginal osteophytes 0–3 3 Two of osteophytosis, joint-space narrowing,
Joint-space narrowing 0–3 subchondral sclerosis, and cyst formation
Subchondral sclerosis 0–1 4 Three of osteophytosis, joint-space narrowing,
Medial subluxation 0–1 subchondral sclerosis, and cyst formation
Lateral subluxation 0–3 5 As in grade 4, but with deformity of the femoral head
(a) (b)
(c) (d)
Fig. 1.5 Grades of severity of OS of the hip: (a) Grade 1; (b) Grade 2; (c) Grade 3; (d) Grade 4.
Source: Reproduced from Silman, A.J. and Hochberg, M.C. (1993). Epidemiology of the Rheumatic Diseases. Oxford: Oxford University Press.
6 1
of musculoskeletal disease in women recruited from a single general prac- In 1981, the Subcommittee on Osteoarthritis of the American College of
tice in Chingford, East London, England.29 They noted that, among the Rheumatology Diagnostic and Therapeutic Criteria Committee was estab-
individual radiographic features of OA, a definite osteophyte in the medial lished to develop clinical criteria for the classification of OA.37 Over the last
compartment was most strongly associated with reported knee pain. The decade, the Subcommittee has developed and published sets of classifica-
odds ratio for the association of grade 1–3 osteophytes with knee pain and tion criteria for OA of the knee,3 hand,38 and hip.39 Altman modified the
the proportion of subjects with grade 1–3 osteophytes who had knee pain criteria sets into algorithms, facilitating their use in clinical research and
were both similar to those for the Kellgren–Lawrence grade 2–4 changes. population-based studies.40 The algorithms for classification of OA of the
In an analysis of data from the Baltimore Longitudinal Study on Aging, knee (Table 1.7), hand (Table 1.8), and hip (Table 1.9), were all developed
Lethbridge-Cejku et al. examined the association of individual radio- using patients with site-specific joint pain due to other types of arthritis or
graphic features and the global Kellgren–Lawrence grade with reported musculoskeletal diseases as the comparison groups. For OA of the knee,
knee pain among 452 men and 223 women, aged 18 and older.30 In support data on 85 historical, physical, laboratory, and radiographic features were
of the findings of Spector et al.,29 they found that the strength of the asso- collected from 130 patients with symptomatic OA of the knee and 105 con-
ciation of definite grade 1–3 osteophytes with current knee pain was simi- trol patients with knee pain due to other etiologies; 55 of the controls had
lar to that for grade 2 or higher OA, using the Kellgren–Lawrence scale; the rheumatoid arthritis.3 For OA of the hand, the Subcommittee collected
odds ratios were 4.4 (95 per cent confidence intervals: 2.6, 7.5) and 4.8 (2.5, data on 51 historical, physical, laboratory, and radiographic features from
8.5), respectively. This relationship was stronger, and remained consistent, 100 patients with symptomatic hand OA and 99 control patients with hand
among the more severe grades of OA: grade 2–3 osteophytes were associ-
ated with current knee pain with an odds ratio of 17.1 (7.5, 38.7), while a
Kellgren–Lawrence grade of 3–4 was associated with current knee pain with Table 1.7 Algorithm for classification of osteoarthritis of the knee,
an odds ratio of 20.8 (8.6, 50.4). Both these studies provided data derived Subcommittee on Osteoarthritis, American College of Rheumatology
from the standing, extended knee radiographs of the tibiofemoral joint. Diagnostic and Therapeutic Criteria Committee*
Felson and colleagues examined the association between clinically
Clinical
diagnosed knee OA, defined as frequent knee symptoms plus crepitus on
physical examination, with radiographic features present on either antero- 1 Knee pain for most days of prior month
posterior weight-bearing or lateral semi-flexed weight-bearing knee radio- 2 Crepitus on active joint motion
graphs.31 The radiographic definitions that best identified knees with 3 Morning stiffness 30 minutes in duration
clinical OA were the presence of a moderate or larger osteophyte, or the
4 Age 38 years
presence of moderate or greater joint-space narrowing plus at least one
5 Bony enlargement of the knee on examination
bony feature (cyst, sclerosis, or osteophyte). Adding information from
the lateral views of the patellofemoral joint enhanced the ability to more Osteoarthritis is present if items 1, 2, 3, 4 or items 1, 2, 5 or items 1 and 5,
efficiently distinguish clinical knee OA from those without clinical knee OA. are present. Sensitivity and specificity are 89 and 88%, respectively.
This study, however, did not have skyline views of the patellofemoral joint, Clinical, laboratory, and radiographic
as illustrated in the atlas published by the Osteoarthritis Research Society 1 Knee pain for most days of prior month
International.22 A study by Lanyon and colleagues, however, did include
2 Osteophytes at joint margins (X-ray spurs)
both an anteroposterior standing and midflexion skyline radiograph of the
knee.32 These authors noted that a case definition based on the presence of 3 Synovial fluid typical of osteoarthritis (laboratory)
a definite osteophyte was more efficient at predicting pain than definitions 4 Age 40 years
based on joint-space width. Furthermore, the addition of the patellofemoral 5 Morning stiffness 30 minutes
joint improved sensitivity for the presence of knee pain. Thus, the use of 6 Crepitus on active joint motion
skyline views of the patellofemoral joint combined with standing views
Osteoarthritis is present if items 1 and 2 or items 1, 3, 5, 6 or items 1, 4, 5,
of the tibiofemoral joint is preferable for epidemiological studies. Based on
6 are present. Sensitivity and specificity are 94 and 88%, respectively.
the validity of the association of individual radiographic features with knee
pain, future population-based epidemiologic studies of OA of the knee * Modified from Refs 3 and 27. Reproduced from Silman, A.J., Hochberg, M.C. (1993).
should rely on the use of individual features alone or in combination to clas- Epidemiology of the Rheumatic Diseases. Oxford: Oxford University Press.
sify cases.33 Protocols for the precise positioning of the tibiofemoral and
patellofemoral compartments of the knee joint have been published.34
Table 1.8 Algorithm for classification of OA of the hand,
Subcommittee on Osteoarthritis, American College of Rheumatology
Clinical criteria
Diagnostic and Therapeutic Criteria Committee*
As noted above, there are potential limitations to the use of only radio-
graphic criteria for a case definition, especially in clinical research studies of Clinical
patients with OA. In particular, although a statistical association exists 1 Hand pain, aching, or stiffness for most days of prior month.
between the radiographic changes of OA and reported pain at both the hip
2 Hard tissue enlargement of 2 of 10 selected hand joints†
and knee, in the individual patient there is often a poor correlation between
the severity of radiographic changes and clinical symptomatology.35 3 Fewer than 3 swollen MCP joints.
At the Third International Symposium on Population Studies of the 4 Hard tissue enlargement of 2 or more DIP joints.
Rheumatic Diseases in 1966, the Subcommittee on Diagnostic Criteria for 5 Deformity of 2 or more of 10 selected hand joints†
Osteoarthrosis recommended that population-based studies should invest- Osteoarthritis is present if items 1, 2, 3, 4 or items 1, 2, 3, 5 are present.
igate the validity of certain historical, physical, and laboratory findings in Sensitivity and specificity are 92 and 98%, respectively.
predicting the typical radiographic features of OA on a joint-by-joint
basis.36 Such historical features include pain on motion, pain at rest, noc- DIP, distal interphalangeal; PIP, proximal interphalangeal; MCP, metacarpophalangeal;
CMC, carpo-metacarpal.
turnal joint pain, and morning stiffness. Features present on physical exam-
ination include bony enlargement and expansion, limitation of motion, * Modified from Refs 25 and 27. Reproduced from Silman, A.J., Hochberg, M.C. (1993).
Epidemiology of the Rheumatic Diseases. Oxford: Oxford University Press.
and crepitus. Laboratory features include the erythrocyte sedimentation † The 10 selected hand joints include bilateral 2nd and 3rd DIP joints, 2nd and 3rd PIP
rate, tests for rheumatoid factor, serum uric acid concentration, and appro-
joints, and 1st CMC joints.
priate analyses of synovial fluid.
1 7
Table 1.9 Algorithm for classification of hip OA, Subcommittee on inter-rater agreement varied by different anatomic sites, it was excellent at
Osteoarthritis, American College of Rheumatology Diagnostic and all sites. The authors concluded that a single experienced assessor could
Therapeutic Criteria Committee* reliably classify subjects as having clinical OA at the hand, hip, and knee.48
In summary, OA is a complex disorder that may result from many
Clinical, laboratory, and radiographic potential etiologies. Definitions of OA developed at multidisciplinary con-
1 Hip pain for most days of the prior month ferences, with international representation of experts, reflect this complex-
2 Femoral and/or acetabular osteophytes on radiograph
ity. It is difficult, however, to apply these definitions to case definition and
diagnosis in the community or clinic setting.
3 Erythrocyte sedimentation rate 20 mm/h
In the community setting, the criteria for case definitions have tradition-
4 Axial joint-space narrowing on radiograph ally relied on the presence of radiographic features of OA, codified using
Osteoarthritis is present if items 1 and 2 or items 1, 3, 4 are present. the Kellgren–Lawrence grading schema as illustrated in the Atlas of Standard
Sensitivity and specificity are 91 and 89%, respectively. Radiographs. Recently, however, the use of reliable atlases for grading the
severity of the individual radiographic features of OA and of modified
* Modified from Refs 26 and 27. Reproduced from Silman, A.J., Hochberg, M.C. (1993).
Epidemiology of the Rheumatic Diseases. Oxford: Oxford University Press. global scales has received an enthusiastic acceptance among rheumatic dis-
ease epidemiologists. In the clinic setting, however, a case definition based
on radiographic features alone have limitations. For purposes of clinical
research, including therapeutic trials, classification criteria have been devel-
pain of other etiologies: 74 had rheumatoid arthritis.38 For OA of the hip,
oped that use combinations of symptoms, physical findings, laboratory data,
data on 76 historical, physical, laboratory, and radiographic features were
and radiographic features, and have high levels of sensitivity and specificity.
collected from 114 patients with symptomatic OA of the hip and 87 control
These classification criteria have been endorsed by the Osteoarthritis
patients with hip pain of other etiologies: 37 had rheumatoid arthritis.39 At
Research Society International, for use as inclusion criteria for patients in
all joint sites, the sensitivity, specificity, and accuracy of these algorithms
clinical research studies, including clinical trials.49,50
approached or exceeded 90 per cent. Misclassification bias, therefore,
would not likely be a major problem in clinical research studies that
employed these criteria.
Because the major inclusion parameter is joint pain on most days of the Key points
prior month, these criteria sets identify patients with clinically important
OA. This contrasts with the identification of cases of OA based on radio- 1. The definition of OA has evolved over the past two decades and now
graphic features alone, insofar as many, if not most, subjects with radio- recognizes OA as a syndrome with many complex etiologies rather
graphic evidence of OA do not report joint pain.35,41 Therefore, estimates than as a single disease entity.
of the prevalence of OA will be lower when based on the American College 2. In epidemiological studies, radiographic criteria remain the basis
of Rheumatology criteria as compared to the traditional radiographic cri- for classifying subjects as having OA.
teria. In population-based studies, misclassification, particularly of false- 3. Clinical criteria identify persons with symptomatic disease and
negative cases, may be considerable because of the high proportion of should be used for the entry of subjects into clinical trials.
subjects with radiographic evidence of OA who do not have joint pain. For
example, in one study of 400 women aged 45–65 years, Hart and colleagues
noted that the prevalence of symptomatic knee OA was only 2.3 per cent References
compared to a prevalence of radiographic knee OA of 17 per cent.42 In
another study of an elderly population in Iceland, Aspelund and colleagues (An asterisk denotes recommended reading.)
noted that the majority of persons who fulfilled the classification criteria 1. Scott, J.C., Lethbridge-Cejku, M., and Hochberg, M.C. (1999).
for hand OA lacked symptoms on most days of the prior month; further- Epidemiology and economic consequences of osteoarthritis: the American
more, symptoms, when present, were episodic in almost one-third of the viewpoint. In: J-Y. Reginster, J-P. Pelletier, J. Martel-Pelletier, and
Y. Henroitin (eds). Osteoarthritis: Clinical and Experimental Aspects. Berlin:
group.43 They concluded that the clinical criteria were of limited use in
Springer, pp. 20–38.
population surveys. Readers need to be aware of the difference between
2. Scott, J.C. and Hochberg, M.C. (1998). Arthritis and other musculoskeletal
prevalence estimates based on radiographic or clinical criteria for case def-
diseases. In: R.C. Brownson, P.L. Remington, and J.R. Davis (eds). Chronic
initions when reviewing published studies.
Disease Epidemiology and Control, 2nd edition. Washington, DC: American
McAlindon and Dieppe reviewed both the process and development of Public Health Association, pp. 465–89.
the American College of Rheumatology criteria for OA of the knee.44 They
3. *Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., et al.
noted several potential limitations, including the lack of age- and gender- (1986). Development of criteria for the classification and reporting of
matched controls, inclusion of controls with rheumatoid arthritis, use of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum
criterion items that were largely subjective and not validated, and the 29:1039–49.
absence of a definition or test for OA. Their comments were echoed by The American College of Rheumatology classification schema for OA as well
Balint and Szebenyi.45 The comments were addressed by Altman et al. who as the preliminary criteria for classification of OA of the knee are provided in
noted that the methodology used to construct the criteria adjusted for dif- this article.
ferences between cases and controls, and that the final items included in the 4. Brandt, K.D., Mankin, H.J., and Shulman, L.E. (1986). Workshop on
criteria sets could be reliably and objectively measured.46 etiopathogenesis of osteoarthritis. J Rheumatol 13:1126–60.
The validity of the criteria for classifying patients with hip OA was exam- 5. Keuttner, K. and Goldberg, V.M. (ed.) (1995). Osteoarthritic Disorders.
ined in a primary care setting.47 The authors noted an excellent agreement Rosemont: American Academy of Orthopedic Surgeons, pp. xxi–v.
between the use of the classification tree approach and the criteria set 6. Kellgren, J.H. and Moore, R. (1952). Generalised osteoarthritis and
including radiographic findings, but poor agreement when only clinical Heberden’s nodes. Br Med J 1:181–7.
variables were included. They suggested that radiographic information was 7. Schumacher, H.R. Jr. (2001). Secondary osteoarthritis. In: R.W. Moskowitz,
necessary to apply the criteria for hip OA in clinical practice. D.S. Howell, R.D. Altman, J.A. Buckwalter, and V.M. Goldberg (eds).
In a more recent study, 85 pairs of twins registered in the Australian Twin Osteoarthritis: Diagnosis and Medical/Surgical Management, 3rd edition.
Registry were examined as part of a study to determine the reliability of Philadelphia: WB Saunders, pp. 327–58.
the ACR clinical criteria.48 Two rheumatologists performed independent 8. *Kellgren, J.H. and Lawrence, J.S. (1957). Radiologic assessment of
clinical assessments blinded to laboratory or radiographic data. While osteoarthrosis. Ann Rheum Dis 16:494–501.
8 1
This landmark paper presents the radiographic features of OA for each of the 32. Lanyon, P., O’Reilly, S., Jones, A., and Doherty, M. (1998). Radiographic
most common sites affected. assessment of symptomatic knee osteoarthritis in the community: defini-
9. The Department of Rheumatology and Medical Illustration, University of tions and normal joint space. Ann Rheum Dis 57:595–601.
Manchester (1973). The Epidemiology of Chronic Rheumatism, Vol. 2, Atlas of 33. Jacobson LT. (1996). Definitions of osteoarthritis in the knee and hand. Ann
Standard Radiographs of Arthritis. Philadelphia: FA Davis, pp. 1–15. Rheum Dis 55:656–8.
10. Spector, T.D. and Cooper, C. (1993). Radiographic assessment of 34. *Buckland-Wright, C. (1995). Protocols for precise radio-anatomical posi-
osteoarthritis in population studies: whither Kellgren and Lawrence? tioning of the tibiofemoral and patellofemoral compartments of the knee.
Osteoarthritis Cart 1:203–6. Osteoarthritis Cart 3(Suppl A):71–80.
11. Spector, T.D. and Hochberg, M.C. (1994). Methodological problems in the This article provides standardized protocols for positioning patients to obtain
epidemiological study of osteoarthritis. Ann Rheum Dis 53:143–6. optimal radiographic views for determining the presence and progression of
12. Hart, D.J. and Spector, T.D. (1995). Radiographic criteria for epidemiologic osteoarthritis.
studies of osteoarthritis. J Rheumatol 22(Suppl 43):46–8. 35. Creamer, P. and Hochberg, M.C. (1997). Why does osteoarthritis of the knee
13. Hart, D.J. and Spector, T.D. (1995). The classification and assessment of hurt—sometimes? Br J Rheumatol 37:726–8.
osteoarthritis. Bailliéres Clin Rheumatol 9:407–32. 36. Bennett, P.H. and Wood, P.H.N. (ed.) (1968). Population Studies of the
14. Kallman, D.A., Wigley, F.M., Scott, W.W. Jr., Hochberg, M.C., and Tobin, J.D. Rheumatic Diseases. International Congress Series No. 148. Excerpta Medica
(1989). New radiographic grading scales for osteoarthritis of the hand. Foundation: Amsterdam, pp. 417–19.
Arthritis Rheum 32:1548–91. 37. Altman, R.D., Meenan, R.F., Hochberg, M.C., Bole, G.G. Jr, Brandt, K.,
15. Croft, P., Cooper, C., Wickham, C., and Coggon, D. (1990). Defining Cooke, T.D.V., et al. (1983). An approach to developing criteria for the
osteoarthritis of the hip for epidemiologic studies. Am J Epidemiol 132:514–22. clinical diagnosis and classification of osteoarthritis: a status report of
16. Lane, N.E., Nevitt, M.C., Genant, H.K., Hochberg, M.C. (1993). Reliability the American Rheumatism Association Diagnostic Subcommittee on
of new indices of radiographic osteoarthritis of the hand and hip and lum- Osteoarthritis. J Rheumatol 10:180–3.
bar disc degeneration. J Rheumatol 20:1911–8. 38. Altman, R., Alarcon, G., Appelrough, D., Bloch, D., Borenstein, D.,
17. Spector, T.D., Cooper, C., Cushnaghan, J., Hart, D.J., and Dieppe, P.A. Brandt, K., et al. (1990). The American College of Rheumatology criteria for
(1992). A Radiographic Atlas of Knee Osteoarthritis. London: Springer. the classification and reporting of osteoarthritis of the hand. Arthritis Rheum
18. Scott, W.W. Jr., Lethbridge-Cejku, M., Reichle, R., Wigley, F.M., Tobin, J.D., 33:1601–10.
and Hochberg, M.C. (1993). Reliability of grading scales for individual radio- 39. Altman R, Alarcon G, Appelrough D, Bloch D, Borenstein D, Brandt K,
graphic features of osteoarthritis of the knee: the Baltimore Longitudinal et al. (1991). The American College of Rheumatology criteria for the classi-
Study of Aging atlas of knee osteoarthritis. Invest Radiol 28:497–501. fication and reporting of osteoarthritis of the hip. Arthritis Rheum 34:
19. Cooke, T.D.V., Kelly, B.P., Harrison, L., Mohamed, G., and Khan, B. (1999). 505–14.
Radiographic grading for knee osteoarthritis: a revised scheme that relates to 40. Altman, R. (1991). Classification of disease: osteoarthritis. Sem Arthritis
alignment and deformity. J Rheumatol 26:641–4. Rheum 20(6,Suppl 2):40–7.
20. Nagaosa, Y., Mateus, M., Hassan, B., Lanyon, P., and Doherty, M. (2000). 41. Lawrence, J.S., Bremner, J.M., and Bier, F. (1966). Osteoarthritis: prevalence
Development of a logically devised line drawing atlas for grading of knee in the population and relationship between symptoms and X-ray changes.
osteoarthritis. Ann Rheum Dis 59:587–95. Ann Rheum Dis 25:1–25.
21. Burnett, S., Hart, D.J., Cooper, C., and Spector, T.D. (1994). A Radiographic 42. Hart, D.J., Leedham-Green, M., and Spector, T.D. (1991). The prevalence of
Atlas of Osteoarthritis. London: Springer. knee osteoarthritis in the general population using different clinical criteria:
22. *Altman, R.D., Hochberg, M.C., Murphy, W.A. Jr., Wolfe, F., and Lequesne, M. the Chingford Study. Br J Rheumatol 30(Suppl. 2):72.
(1995). Atlas of individual radiographic features in osteoarthritis. 43. Alpelund, G., Gunnarsdottir, S., Jonsson, P., and Jonsson, H. (1996).
Osteoarthritis Cart 3(Suppl. A):3–70. Hand osteoarthritis in the elderly: application of clinical criteria. Scand J
The photographs reproduced in this paper are the standards developed by Rheumatol 25:34–6.
the Osteoarthritis Research Society International (OARSI) for grading the indi- 44. McAlindon, T. and Dieppe, P. (1989). Osteoarthritis: definitions and
vidual radiographic features of OA at the most common sites affected. criteria. Ann Rheum Dis 48:531–2.
23. Lane, N.E. and Kremer, L.B. (1995). Radiographic indices for osteoarthritis. 45. Balint, G. and Szebenyi, B. (1996). Diagnosis of osteoarthritis: guidelines
Rheum Dis Clin North Am 21:379–94. and current pitfalls. Drugs 52(Suppl. 3):1–13.
24. Sun, Y., Gunther, K.P., and Brenner, H. (1997). Reliability of radiographic 46. Altman, R.D., Bloch, D.A., Brandt, K.D., Cooke, D.V., Greenwald, R.A.,
grading of osteoarthritis of the hip and knee. Scand J Rheumatol 36:155–65. Hochberg, M.C., et al. (1990). Osteoarthritis: definitions and criteria. Ann
25. Bellamy, N., Tesar, P., Walker, D., Klestov, A., Muirden, K., Kuhnert P, et al. Rheum Dis 49:201.
(1999). Perceptual variation in grading hand, hip and knee radiographs: 47. Bierma-Zeinstra, S., Bohnen, A., Ginai, A., Prins, A., and Verhaar, J. (1999).
observations based on an Australian twin registry study of osteoarthritis. Validity of American College of Rheumatology criteria for diagnosing hip
Ann Rheum Dis 58:766–9. osteoarthritis in primary care research. J Rheumatol 26:1129–33.
26. Scott, J.C., Nevitt, M.C., Lane, N.E., Genant, H.K., and Hochberg, M.C. 48. Bellamy, N., Klestov, A., Muriden, K., Kuhnert, P., Do, K.A., O’Gorman, L.,
(1992). Association of individual radiographic features of hip osteoarthritis and Martin, N. (1999). Perceptual variation in categorizing individuals
with pain. Arthritis Rheum 35(Suppl. 9):S81. according to American College of Rheumatology classification criteria for
27. Ingvarsson, T., Hagglund, G., Lindberg, H., Lohmander, L.S. (2000). hand, knee, and hip osteoarthritis (OA): observations based on an
Assessment of primary hip osteoarthritis: comparison of radiographic Australian Twin Registry study of OA. J Rheumatol 26:2654–8.
methods using colon radiographs. Ann Rheum Dis 59:650–3. 49. Altman, R., Brandt, K., Hochberg, M., and Moskowitz, R. (for the Task
28. Nevitt, M.C. (1996). Definition of hip osteoarthritis for epidemiological Force) (1996). Design and conduct of clinical trials in patients with
studies. Ann Rheum Dis 55:652–5. osteoarthritis: recommendations from a task force of the Osteoarthritis
Research Society. Osteoarthritis Cart 4:217–43.
29. Spector, T.D., Hart, D.J., Byrne, J., Harris, P.A., Dacre, J.E., and Doyle, D.V.
(1993). Defining the presence of osteoarthritis of the knee in epidemiologic This article provides the OARSI guidelines for designing and conducting
studies. Ann Rheum Dis 52:790–4. trials in patients with osteoarthritis of the hip or knee. A companion article
on guidelines for designing and conducting trials in patients with osteoarthritis
30. Lethbridge-Cejku, M., Scott, W.W. Jr, Reichle, R., Ettinger, W.H.,
of the hand is in preparation and will be published in Osteoarthritis Cart
Zonderman, A., Costa, P., et al. (1995). Association of radiographic features
in 2002.
of osteoarthritis of the knee with knee pain: Data from the Baltimore
Longitudinal Study of Aging. Arthritis Care Res 9:182–8. 50. Altman, R. and Maheu, E. (for the Task Force) (2002). Design and conduct
of clinical trials in patients with osteoarthritis of the hand: recommenda-
31. Felson, D.T., McAlindon, T.E., Anderson, J.J., Naimark, A., Weissman, B.W.,
tions from a task force of the Osteoarthritis Research Society. Osteoarthritis
Aliabadi, P., et al. (1997). Defining radiographic osteoarthritis for the whole
Cart 10:in press.
knee. Osteoarthritis Cart 5:241–50.
2 Epidemiology of osteoarthritis
David T. Felson
studies from the United States of America and Europe suggest that radio-
Impact of OA graphic hip OA occurs in roughly 3–4 per cent of elders.5
Osteoarthritis is the most common form of arthritis. Its high prevalence, Symptomatic OA is generally defined as frequent joint pain plus radio-
especially in the elderly, and the frequency of OA-related physical disability graphic change; its prevalence in the knee has ranged in different studies
make OA one of the leading causes of disability in the elderly, especially from 1.6–9.4 per cent of adults and in 10–15 per cent of elders.
with respect to weight-bearing functional tasks.1 According to a report on Symptomatic hip OA occurs in anywhere from 0.7–4.4 per cent of adults,
the prevalence of arthritis: ‘By 2020 the estimated number of persons with and, using British data from the 1960s, symptomatic hand OA occurs in
arthritis is projected to increase by 57 per cent and activity limitations asso- about 2.6 per cent of adults.
ciated with arthritis by 66 per cent’. These projected increases are largely The prevalence of knee pain and OA by radiograph represents a good
attributable to the high prevalence of OA among older persons and the example of how the prevalence of OA differs depending on how the disease
increasing average age of the US population.2 is defined. Approximately 25 per cent of adults aged 55 and over experience
Epidemiology is the study of disease in populations and its association knee pain for a prolonged period every year (lasting at least a month).
with characteristics of people and their environments. Epidemiological Of these, roughly half have evidence of radiographic OA6 (see Fig. 2.1).
studies document the burden of disease in society and evaluate risk factors Even though they have frequent knee pain, many of these persons do not
for disease that, if modified, might lead to disease prevention and a lessen- necessarily experience limited function from this pain, so that when one
ing of the burden of disability associated with disease. Identifying modifi- addresses the prevalence of knee pain with limitation, it is roughly half the
able risk factors for OA is the first step to prevent this disease and lower its previous prevalence. Severely disabling knee pain is relatively uncommon.
formidable burden in our society. A similar relationship between disabling joint pain and radiographic
change exists for most regions of the body affected by OA.
The prevalence of OA in all joints is strikingly correlated with age.
Prevalence and incidence of OA Regardless of how OA is defined, it is uncommon in adults aged under 40
Osteoarthritis is an extremely common joint disorder in all populations. It and extremely prevalent in those aged above 60. Radiographic hand OA, for
often affects certain joints, yet spares others. For example, in the hands, the example, was present in only about 5 per cent of adults aged under 35, but
distal interphalangeal (DIP), proximal interphalangeal (PIP) joints, and the was seen in over 70 per cent of those who were aged 65 or older.7
carpometacarpal (CMC) joint of the thumb are frequently involved. Other Osteoarthritis has a higher prevalence, and more often exhibits a gen-
joints commonly affected include the cervical spine, lumbosacral spine, hip, eralized distribution, in women than in men. Before the age of 50, men
knee, and first metatarsophalangeal (MTP) joint. The ankle, wrist, elbow, have a higher prevalence than women, but after the age of 50 women have
and shoulder are usually spared. Our joints were designed and shaped, in an a higher prevalence, and this sex difference in prevalence further increases
evolutionary sense, when humans were brachiating apes. Only later did with age.8,9 These gender and age-related prevalence patterns are consistent
humans develop a pincer grip capability3 and full weight-bearing on their with a role of post-menopausal hormone deficiency in increasing the risk
legs. These evolutionary differences in joint function and, possibly, differ- of OA.
ences in the composition of articular cartilage among the different joints, Cross-national and cross-racial studies often produce insights about dis-
predispose some joints to cartilage breakdown, leading to OA. ease etiology. With respect to OA, black women have been reported to have
Osteoarthritis can be defined in many ways. On the one hand, there is higher rates of knee OA than white women10 even after adjustment for age
structural change in a joint often assessed by radiograph. Radiographic and weight. The results in black men have been inconsistent. However,
changes of OA include osteophytes and joint-space narrowing, the latter studies suggest very low rates of hip OA among the black populations in
reflecting cartilage loss. Many persons with radiographic OA do not have Jamaica, South Africa, Nigeria, and Liberia (1–4 per cent for radiographic
joint symptoms. Secondly, one can assess the occurrence of joint symp- OA), in comparison with European populations (7–25 per cent). In
toms. While this is an appealing definition from a clinical and public health Blackfeet and Pima Native Americans, the rates of hip OA are intermediate
standpoint, many with joint symptoms do not have radiographic changes between those for blacks and whites,11 even though the Pimas weigh more,
of disease and may not have OA. Prevalence estimates across studies vary on average, than Caucasians.
because of the inconsistent definitions of symptoms and radiographic The rates of hip OA are much lower in Asians than in Caucasians. The
change. The only exception to this is the Kellgren and Lawrence scale, rate of hip arthroplasty for OA in people of Asian extraction is lower
which has been widely used to evaluate the prevalence of radiographic OA than that in Caucasians in the United States of America.12 Using standard
in most joints. methods across population-based groups, Nevitt et al.13 report that symp-
Radiographic disease is highly prevalent with radiographic hand OA tomatic and radiographic hip OA are far less prevalent in Chinese than in
occurring in approximately 32.5 per cent of adults aged 30 and over.4 The Caucasians from the United States of America. The low rate of hip OA in
prevalence of radiographic knee and hip OA has been best studied in the Asians is not matched by a low rate of knee OA, as Zhang et al.14 using stand-
population surveys of elders. The Framingham Study suggests that radio- ardized methods across populations, found that knee OA prevalence was
graphic knee OA occurs in 33 per cent of people aged 63 and over, and actually more prevalent in Chinese than in Caucasian women and equally
10 2
4 Weeks of knee
2500
pain in past year
0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10 000
Fig. 2.1 Prevalence of knee pain and osteoarthritis in persons aged 55 and over. *The proportion with radiographic evidence in this category is not known, though it
seems likely to be high. The shading represents the proportion in each category with radiographic evidence of knee osteoarthritis.
Source: Taken from Peat et al.6
prevalent among men. Although it was initially felt that these racial 1200
differences in hip OA prevalence might be attributed to an absence of Hand males
developmental hip abnormalities in Asians, studies of the Chinese in Incidence rate per 100 000 person-years 1000
Hand females
Hong Kong15,16 fail to confirm a lower prevalence of developmental hip Hip male
× × Hip female
abnormalities. Thus, the explanation for these racial differences in preval-
Knee male
ence is unclear. 800
Knee female
Generalized OA involves hand joints, including the DIP, PIP, and the first
CMC joints; cervical spine; lumbosacral spine and knees; and may include
the hips. There are two types of generalized OA: nodal OA (Heberden’s 600 ×
nodes) and non-nodal OA.17 There is little question that this entity exists;
OA in one joint is associated with the presence of OA in other joints, even ×
400
after adjusting for age and sex. Generalized OA is most common in older
women and may be inherited in a polygenic pattern.18 ×
Because the risk of mortality may be increased in those with OA19,20 200
prevalence estimates may give erroneous estimates of actual disease incid-
ence, that is the new occurrence of disease. A large-scale study from a ×
0× × ×
Massachusetts health maintenance organization21 reported that the age-
20–29 30–39 40–49 50–59 60–69 70–79 80–89
and sex-standardized incidence rate for symptomatic hand OA was 100 per
Age group (years)
100 000 person years. For hip OA the rate was 88 per 100 000 person years
and for knee OA 240 per 100 000 person years. The incidence of hand, knee,
Fig. 2.2 Incidence of OA of the hand, hip, and knee, in members of the Fallon
and hip OA all increased with age (Fig. 2.2) and for each joint was higher in
Community Health Plan, 1991–2, by age and sex.
women than in men after the age of 50. At the age of 70–89, the knee OA
Source: Taken from Oliveria et al.21
rates among women reached a maximum incidence of 1 per cent per year.
Interestingly, a leveling off or decline in the incidence of symptomatic OA
occurred in both sexes around the age of 80. In studies in which serial knee
radiographs were obtained,22 rates of incident symptomatic OA in women
were 1 per cent per year. Radiographic OA of the knee (often asymptomatic) Risk factors for OA
was more frequent with an incidence of 2 per cent per year in women.23 Individual joints become especially susceptible to OA when local factors in
the joint combine with systemic vulnerability. Such local factors might
The descriptive epidemiology of OA include joint deformity or malalignment, but by far the most common local
factor we recognize is previous major injury to a joint, which has left the
◆ The most common form of arthritis
joint vulnerable. Local factors may be powerful determinants of OA by
◆ Occurs most frequently in knees, hands (DIPs, PIPs, MCPs, thumb themselves such that a joint may be sufficiently deformed or affected by a
base), hips, back, neck and spares wrists, ankles major injury as to inevitably lead to OA. But more commonly, this injury
◆ Incidence and prevalence higher in women than in men, especially
acts on a joint within a person whose own systemic vulnerability to OA
varies depending on their age and other factors. Thus, in many cases there
after the age of 50
is interplay of systemic and local vulnerability factors.
◆ Many have joint symptoms without X-ray change and vice versa Within that local and systemic environment, a variety of loading-related
◆ Emerging information on racial differences in occurrence may factors exert influence over whether a joint develops OA. The primary
provide etiologic clues to disease factors are obesity and particular physical activities, which we shall call
extrinsic factors (see Fig. 2.3). Thus, a person who participates in activities
2 11
ligament and meniscal tears are common causes of knee OA especially Does losing weight lower the risk of OA? For the Framingham women
among men.47,48 Such injuries are prevalent49 in young women athletes and whose baseline BMI values were greater than 25, that is, greater than the
increase their risk of developing OA at a young age. Epidemiologic studies median, weight loss significantly lowered the rate of incident symptomatic
have documented that those with a history of major knee injury are a high knee OA.63 The adjusted odds ratio per two units of BMI (approximately
risk of later, usually ipsilateral, knee OA. In the Framingham study,50 men 5 kg for a woman of normal height) was 0.41, a reduction of more than
with a history of major knee injuries had a relative risk of 3.5 for subsequent 50 per cent in the risk of developing knee OA. Weight gain was associated
knee OA; for women the relative risk was 2.2 (both p 0.05). At sites in with a slightly increased rate of subsequent knee OA (odds ratio 1.28 for a
which the disease is generally uncommon, for example, the ankle and two-unit weight gain). For women whose baseline weight was lower than
shoulder joints, major joint injury may account for a large proportion of all the median, neither weight gain nor weight loss significantly affected their
cases of OA. risk of later disease.
There is clearly interplay between systemic and local injury factors. For Substantial weight loss (dropping from obese to overweight, or from
example, those sustaining major knee injuries of their knees develop OA in overweight to normal weight range) would prevent about 21 per cent of
the knees rapidly if they are older but are less likely to develop OA with such knee OA in men; in women (in whom the association of obesity and knee
rapidity if they are younger.51 Either partial or complete meniscus removal, OA is stronger), 33 per cent of knee OA would be prevented.64 For women,
done when the meniscus is injured increases local stresses and laxity within weight accounts for more OA than any other known factor; for men, over-
the knee52 and is itself a prominent cause of OA.53 Hip injuries may also weight is second to knee injury as a preventable cause of knee OA.
cause OA there, but longitudinal studies evaluating this issue are lacking. Not only does being overweight increase the risk for OA, but for those
Other local risk factors. Those with joint deformities from fractures, with established knee OA it increases the odds of disease progression.65–67
osteonecrosis, or other reasons are at high risk for OA also because of the Furthermore, those with OA in one knee are at higher risk of developing
biomechanical modifications that occur with joint deformity. This consti- OA in the other knee if they are overweight.68 The effect of obesity on OA
tutes one of the reasons why those with destructive inflammatory arthritis progression in joints other than the knee has not been studied.
are at a high risk for getting secondary OA. Lastly, malalignment especially In those who already have OA, weight change is likely to affect symp-
in the knees has recently been linked to rapid disease progression for those toms. McGoey et al.69 studied morbidly obese women at the time of their
who already have knee OA.54 By altering loading across joints, malalign- gastric stapling operation and one year later, at which time their mean
ment may contribute to OA incidence in the knees and other joints. weight loss was approximately 45 kg. The proportion with knee symptoms
dropped from 57 to 14 per cent during this interval and the prevalence of
other regional symptoms, for example, hip pain and back pain, fell com-
Extrinsic risk factors (factors acting on mensurately. Unfortunately, the authors did not definitively ascertain
the joint) whether these subjects had OA.
In another study, 30 obese women (48.7 per cent above ideal weight)
Obesity. Population-based studies consistently show that overweight per-
with knee or hip OA were randomized to phentermine, an appetite sup-
sons are at higher risk of knee OA than non-overweight controls. Estimates
pressant, or placebo, with all subjects instructed to eat a low-energy diet.70
of risk vary from population to population and depend, to some degree, on
Six months later, among 22 patients who remained in the trial, those taking
the criteria for overweight and the definition of OA. In NHANES I, which
phentermine had lost 6.3 kg and those in the placebo group 4.5 kg (p NS).
was conducted throughout the United States of America from 1971–5,55 the
The amount of weight loss correlated significantly with improvement in a
risk of radiographic OA in obese women (body mass index, BMI, greater
clinical score, which combined symptoms and physical findings. For knee
than 30 but less than 35) was almost four times that in women whose BMI
OA, the correlation between weight loss and improvement was especially
was lower than 25. For men in the same overweight category the risk was 4.8
strong (r 0.66, p 0.01).
times greater than that for men of normal weight. Three to six times body
weight is exerted across the knee during single leg stance in walking;56 Muscle weakness. It has long been recognized that persons with knee OA
therefore, any increase in weight may be multiplied by this factor to reveal have weaker quadriceps than those without the disease.71,72 In a longitud-
the excess force across the knee of an overweight person during walking. In inal follow-up study, women with incident knee OA were weaker at baseline
addition to increasing the risk of tibiofemoral OA, obesity augments the than women who did not develop knee OA.73 The same was not necessarily
risk of disease in the patellofemoral joint. Not only does obesity occur with true for men, but the numbers were small. Quadriceps contraction may
knee OA more than expected, it actually57,58 precedes the development decelerate impulse loading during gait and therefore protect the knee from
of knee OA, suggesting it causes disease, probably through excess loading. damage.74 Since muscle contraction across a joint may be the main source
The relation of obesity to hip OA is weaker than with knee OA, a difference of joint loading, strength may not protect all joints from getting OA.
that is possibly due to the different multiplier effects of body weight across Increased grip strength has been found to be associated with high rates of
the two joint sites or differences in distribution of load across the hip and OA in proximal hand joints like the MCP and base of the thumb, suggesting
knee during weight-bearing.59 that increased loading on the basis of powerful muscle contraction can
Weight could act to cause OA via two mechanisms: first, and most logi- actually damage joints.75
cally, because it increases the amount of load across a joint, obesity could Repeated use of joint. There are two types of activities that involve the
induce cartilage breakdown simply on the basis of excess load. This could repeated use of a joint and have been the focus of epidemiologic studies,
account for the apparent causal relationship between weight and knee and occupational and athletic activities.
hip OA. Indeed, the association of obesity and knee OA is so strong that it Occupational activities and OA. Farmers are at high risk for hip OA. Among
is not likely to be explained by confounding factors. Surprisingly, people farmers, standing, bending, walking long distances over rough ground, lift-
who are overweight may be at slightly higher risk of hand OA.60 The load ing, moving heavy objects, and tractor driving all appear to pose high risks
theory does not explain the relationship between overweight and hand OA, for hip OA, while climbing was not implicated as a risk factor.76
which suggests the involvement of a systemic factor. Following this line of Also, jackhammer operators have a high rate of OA in the upper extrem-
reasoning, it has been speculated that a circulating factor that acts to accel- ity joints that are otherwise rarely affected by disease. Jackhammers impart
erate cartilage breakdown may be present in overweight persons, serving as high impulse loads across joints that are not designed to sustain them.
a second mechanism leading to OA. Vibratory tools may subvert the effectiveness of joint shock absorbers, such
In addition, bone mineral density is increased in overweight persons and as muscles, leading to the transmission of excess stress across the joint and
this (or the absence of osteoporosis) may be a risk factor for OA.61 Additional leading to joint injury.
evidence in favor of a systemic factor is the possibility that the relationship Miners have high rates of OA in the knees and spine,77 while shipyard
between overweight and OA is stronger in women than in men.62 and dockyard workers have a higher prevalence of OA in the knees and
2 13
fingers than office workers. Cotton mill workers may have high rates of Like occupational activities, OA in athletes seems to occur in especially
hand OA compared to controls.78 over-used joints so that weight lifters who squat and then lift heavy weights
While there are jobs that clearly predispose to OA through joint overuse, have a high risk of patellofemoral OA, whereas soccer players have a higher
there are stereotyped activities that themselves cause OA. Women whose risk of tibiofemoral knee OA.87
jobs require a fine pincer grip (increasing the stress across DIP joints) in a Given the widespread prescription to adopt a healthier more exercise-
Virginia textile mill had significantly more DIP joint OA than women filled lifestyle, large-scale longitudinal epidemiologic studies of the conse-
whose jobs required repeated power grip, a motion that does not stress the quences of exercise on OA contain cautionary notes. In a large-scale study
DIP joints.79 Workers whose jobs required regular knee bending and lifting of women followed for hip OA, those with increased levels of physical activ-
or carrying heavy loads80–83 had a higher rate of knee OA than workers ity either as a teenager or at age 50 were at a higher risk of developing symp-
whose jobs did not entail these activities. tomatic OA later in life88 than women who were sedentary. In a prospective
With respect to the prevention of OA, occupational activities may be follow-up of elders in Framingham, those who reported heavy physical
extremely important. In a study of older male workers, the proportion activity were at a three-fold increased risk of developing both radiographic
of OA potentially attributable to occupational knee bending was higher and symptomatic knee OA at follow-up compared to those who were inact-
(32 per cent) than that attributable to obesity (24 per cent).84 If specific ive. Not all literature is consistent on this matter, however.89 Since physical
job-related tasks, which increase the risk of OA, were changed or avoided activity in general has so many salutatory effects, identifying the particular
many cases of OA would be prevented. Unfortunately, occupation-related activities that pose risks of long-term joint damage (such as those listed
OA is not an easy target for disease prevention. Jobs contain complex above) is preferred to stigmatizing physical activity because it might, in
ergonomic activities and isolating the injurious ones may be difficult. Also, some cases, be risky. Because of the systemic vulnerability to OA among
workers often change jobs or rotate to other tasks. Elimination of all jobs those who are aged, this group may be at a high risk of OA when they
involving substantial physical labor is not realistic, but minor alterations in become physically active later in life.90
ergonomic activities might lower job-related OA risk if specific tasks are
shown as being linked to a high rate of OA.
Leisure time physical activities and OA. With exercise already assuming a
major role in OA treatment, it appears paradoxical to consider the idea that
exercise per se may actually cause OA. But the evidence suggests that certain Risk factors for symptoms
types of exercise may indeed do so. The association of running with OA is of Only approximately half of those with radiographic OA have frequent joint
special interest (see Table 2.1). Most studies evaluating recreational running symptoms. From a clinical and public health perspective, understanding the
have not shown that runners have an increased risk of knee OA, although etiology of joint symptoms is critical. In a recent MRI-based study in which
studies of hip OA have not been consistent. What has emerged, however, is those with knee symptoms were compared to others of a comparable age
an intriguing relation between elite running85 and OA of both the knee and and radiographic disease, MRI features that distinguished those with knee
hip. Professional runners and those on Olympic teams followed over time symptoms from those without were bone marrow edema lesions, synovial
have substantially higher rates of OA in weight-bearing joints than age- thickening, and effusions.91 Large bone marrow edema lesions were present
matched controls. Studies of recreational runners have two important almost exclusively in those with knee pain and were absent in those without
methodological limitations: first, they often miss persons who stop running it, even if they had radiographic disease. Symptom severity was strongly
because they develop knee or hip pain because of early disease and secondly, correlated with an MRI finding of synovitis.92 Findings from this study
they often fail to have information on and adjust for a history of major knee suggest that synovial inflammation and its product, joint effusion, and
injury. One study suggests that runners who get OA are those with the his- bone marrow lesions might be uniquely correlated with the development of
tory of major knee injury.86 knee pain.
Author (year) Joint No. of subjects Time elapsed since OA in runners compared to controls
running (years)
Sohn and Micheli (1985) Knee 504 25 No increase in knee complaints over
controls (swimmers)
Lane et al. (1993) Knee 33 5 No increase in OA
Panush (1994) Knee 12 8 No increase in OA
Harris et al. (1995) Knee 73 0–40 Increase in osteophytes in runners
Kujala et al. (1995)* Knee 28 35 Non-significant increase (OR 4.8)
of knee OA in runners vs. shooters
Spector et al. (1996)* Knee 73 0–40 Increase in osteophytes in runners
Puranen (1975)* Hip 60 20 No increase in OA
Marti et al. (1989)* Hip 27 15 Runners had more OA than controls
Vingard et al. (1993)* Hip, Knee 233 20–50 Runners had more OA (RR 2.1, p NS)
Kujala et al. (1994) Hip, 100 30 Runners had more hospitalization for knee
and Ankle and hip OA (RR 1.8; 95% CI 0.9–3.6)
Cheng et al. (2000) Hip and Knee 16 0–25 Male but not female runners ( 20 miles/week)
had more OA than non-runners
(OR 1.6; 95% CI 1.1–2.3)
Table 2.2 Do biomechanical factors affect the knee differently at 7. Engel, A. (1968). Osteoarthritis and body measurements. Rockville MD:
different stages of OA? National Center for Health Statistics, Series 11, no. 29, PHS publication
no. 1999.
Odds ratio for 8. Felson, D.T., Naimark, A., Anderson, J., Kazis, L., Castelli, W., and
Incident (new) disease Progressive disease
Meenan, R.F. (1987). The prevalence of knee osteoarthritis in the elderly.
Arthritis Rheum 30(8):914–18.
High BMI* 9.1 2.6 9. Van Saase, J.L.C.M., Van Romunde, L.K.J., Cats, A., Vandenbroucke, J.P.,
Previous knee injury* 4.8 1.2 and Valkenburg, H.A. (1989). Epidemiology of osteoarthritis: Zoetermeer
survey. Comparison of radiological osteoarthritis in a Dutch population
Regular sports* 3.2 0.7
with that in 10 other populations. Ann Rheum Dis 48:271–80.
High bone density† 2.3 0.1 10. Anderson, J. and Felson, D.T. (1988). Factors associated with osteoarthritis
* Taken from Cooper et al., 2000.94 of the knee in the First National Health and Nutrition Examination Survey
(NHANES I). Am J Epidemiol 128:179–89.
† Taken from Zhang et al., 2000.33
11. Lawrence, J.S. and Sebo, M. (1980). ‘The geography of osteoarthritis’. In
The Aetiopathogenesis of Osteoarthritis, Baltimore: University Park Press,
pp. 155–83.
12. Hoaglund, F.T., Oishi, C.S., and Gialamas, G.G. (1995). Extreme variations
in racial rates of total hip arthroplasty for primary coxarthrosis: A
population-based study in San Francisco. Ann Rheum Dis 54:107–10.
Risk factors for incidence vs. progression 13. Nevitt, M., Xu, L., Zhang, Y., et al. (2000). Chinese in Beijing have a very low
prevalence of hip OA compared to U.S. Caucasians. Arthritis Rheum
Many of the risk factors discussed above may operate differently on joints at 43:S171.
different stages of disease. Studies have suggested, for example, that vitamin 14. Zhang, Y., Xu, L., Nevitt, M.C., et al. (2001). Comparison of the prevalence
D deficiency may accelerate the risk of OA progression but does not appear of knee osteoarthritis between the elderly Chinese population in Beijing and
to affect the risk of incident disease. Vitamin C deficiency may have similar Whites in the U.S.: The Beijing Osteoarthritis Study. Arthritis Rheum
effects.89 As noted above, bone density may actually have opposite effects at 44:2065–71.
different disease stages with high bone density increasing the risk of inci- 15. Hoaglund, F.T., Yau, A.C.M.C., and Wong, W.I. (1973). Osteoarthritis of the
dent disease yet delaying progression. Some factors such as obesity, pre- hip and other joints in Southern Chinese in Hong Kong. J Bone Joint Surg
vious knee injury, and regular sports prescriptions, have been strongly 55(A):545–57.
linked to incidence yet in the same populations appear unrelated to the risk 16. Lau, E. and Lin, F. (1994). Low prevalence of osteoarthritis of the hip in
of progression90 (see Table 2.2). Chinese men. Arthritis Rheum 37(Suppl.):S239.
It would be unusual if risk factors varied at different stages of the disease, 17. Kellgren, J.H. and Moore, R. (1952). Generalized osteoarthritis and
but when disease is present the joint becomes more vulnerable and one Heberden’s nodes. Br Med J 1:181–7.
might expect risk factors to act in a more potent fashion, although the data 18. Lawrence, J.S. (1977). Osteoarthrosis. In J.S. Lawrence (ed.). Rheumatism in
do not necessarily suggest they do. Other explanations for the differences Populations. London: Heinemann.
reported between risk factors for incidence and progression include: the 19. Cerhan, J.R., Wallace, R.B., El-Khoury, G.Y., Moore, T.E., and Long, C.R.
numbers are small in each of these studies and differences reported may not (1995). Decreased survival with increasing prevalence of full-body, radi-
reflect real ones; risk factors for incidence are really risk factors for osteo- ographically defined osteoarthritis in women. Am J Epidemiol 141:225–34.
phytes and those for progression are risk factors for joint space or cartilage 20. Monson, R.R. and Hall, A.P. (1976). Mortality among arthritics. J Chronic
loss; and lastly that risk factors really do differ at different stages of the Dis 29:359–467.
disease perhaps because of the different metabolic or restorative powers of 21. Oliveria, S.A., Felson, D.T., Reed, J.I., Cirillo, P.A., and Walker, A.M.
the joint. (1995). Incidence of symptomatic hand, hip, and knee osteoarthritis
among patients in a health maintenance organization. Arthritis Rheum
38:1134–41.
22. Felson, D.T., Zhang, Y., Hannan, M.T., et al. (1995). The Incidence and
References natural history of knee osteoarthritis in the elderly: The Framingham
Osteoarthritis Study. Arthritis Rheum 38:1500–5.
(An asterisk denotes recommended reading.) 23. Hart, D.J., Doyle, D.V., and Spector, T. (1999). Incidence and risk factors for
1. Guccione, A.A., Felson, D.T., Anderson, J.J., et al. (1994). The effects of radiographic knee osteoarthritis in middle-aged women. Arthritis Rheum
specific medical conditions on the functional limitations of elders in the 42:17–24.
Framingham Study. Am J Public Health 84:351–8. 24. Demissie, S., Cupples, L.A., Myers, R., Aliabadi, P., Levy, D., and Felson, D.T.
2. US Department of Health and Human Services (1995). CDC: Prevalence (2002). Genome scan for quantity of hand osteoarthritis: the Framingham
and impact of arthritis among women—United States, 1989–1991. MMWR study. Arthritis Rheum 46:946–52.
44:329–34. 25. *Spector, T.D., Cicuttini, F., Baker, J., Loughlin, J., and Hart, D. (1996).
3. Hutton, C.W. (1987). Hypothesis. Generalised osteoarthritis: an evolution- Genetic influences on osteoarthritis in women: a twin study. Br Med J
ary problem? Lancet 1:1463–5. 312:940–4.
4. Lawrence, R.C., Helmick, C.G., Arnett, F.C., et al. (1998). Estimates of the In data from a large twin study, these investigators reported that radiographic
prevalence of arthritis and selected musculoskeletal disorders in the United OA was highly heritable, especially OA in the hand joints.
States. Arthritis Rheum 41:778–99. 26. Hart, D.J., Mootoosamy, I., Doyle, D.V., and Spector, T.D. (1994). The rela-
5. Nevitt, M.C., Lane, N.C., Scott, J.C., et al. (1995). Radiographic osteoarthri- tionship between osteoarthritis and osteoporosis in the general population:
tis of the hip and bone mineral density. Arthritis Rheum 38:907–16. the Chingford Study. Ann Rheum Dis 53:158–62.
6. *Peat, G., McCarney, R., and Croft, P. (2001). Knee pain and osteoarthritis 27. Gevers, G., Dequeker, J., Martens, M., et al. (1989). Biomechanical char-
in older adults: a review of community burden and current use of primary acteristics of iliac crest bone in elderly women according to osteoarthritis
health care. Ann Rheum Dis 60:91–7. grade at the hand joints. J Rheumatol 16:660–3.
This article provides a clear explanation and supporting data on the preva- 28. Dequeker, J., Boonen, N., Aerssens, J., Westhovens, R. (1996). Inverse
lence of knee pain and OA in the community and how these vary depending on relationship osteoarthritis–osteoporosis: what is the evidence? What are the
the definition. consequences? (Editorial). Br J Rheumatol 35:813–20.
2 15
29. Hannan, M.T., Anderson, J.J., Zhang, Y., Levy, D., and Felson, D.T. (1993). 51. *Roos, H.P., Adalberth, T., Dahlberg, L., Lohmander, L.S. (1995).
Bone mineral density and knee osteoarthritis in elderly men and women. Osteoarthritis of the knee after injury to the anterior cruciate ligament or
Arthritis Rheum 36:1671–80. meniscus: the influence of time and age. Osteoarthritis Cart 3:261–7.
30. Rogers, J., Shepstone, L., Dieppe, P. (1997). Bone formers: osteophyte An important article suggesting that knee injury causes accelerated develop-
and enthesophyte formation are positively associated. Ann Rheum Dis ment of OA if it occurs after age 30.
56:85–90. 52. Walker, P.S., Erkman, M.J. (1975). The role of the menisci in force transmis-
31. Sowers, M., Lachance, L., Jamadar, D., et al. (1999). The associations of sion across the knee. Clin Orthop Rel Res 109:184–192.
bone mineral density and bone turnover markers with osteoarthritis of the 53. Englund, M., Roos, E.M., Roos, H.P., Lohmander, L.S. (2001). Patient-
hand and knee in pre- and perimenopausal women. Arthritis Rheum relevant outcomes fourteen years after meniscectomy: influence of types of
42:483–9. meniscal tear and size of resection. Rheumatology 40:631–639.
32. Zhang, Y., Hannan, M.T., Chaisson, C.E., et al. (2000). Bone mineral density 54. Sharma, L., Song, J., Felson, D.T., Cahue, S., Shamiyeh, E., Dunlop, D.D.
and risk of incident and progressive radiographic knee osteoarthritis in (2001). The role of knee alignment in disease progression and functional
women: the Framingham study. J Rheumatol 27:1032–7. decline in knee osteoarthritis. JAMA 286:188–195.
33. Kellgren, J.H. and Moore, R. (1952). Generalized osteoarthritis and 55. Anderson, J. and Felson, D.T. (1988). Factors associated with osteoarthritis
Heberden’s nodes. Br Med J 1:181–7. of the knee in the First National Health and Nutrition Examination Survey
34. Nevitt, M.C., Cummings, S.R., Lane, N.E., Genant, H.K., and (NHANES I). Am J Epidemiol 128:179–89.
Pressman, A.R. (1994). Current use of oral estrogen is associated with a 56. Maquet, P. (1976). Biomechanics of the Knee. Springer-Verlag, New York.
decreased prevalence of radiographic hip OA in elderly white women. 57. Felson, D.T., Anderson, J.J., Naimark, A., Walker, A.M. and Meenan, R.F.
Arthritis Rheum 37(Suppl.):S212. (1988). Obesity and knee osteoarthritis. Ann Intern Med 109:18–24.
35. Hannan, M.T., Felson, D.T., Anderson, J.J., Naimark, A., and Kannel, W.B. 58. Schouten, J. (1991). A 12-year follow-up study of osteoarthritis of the knee
(1990). Estrogen use and radiographic osteoarthritis of the knee in women. in the general population, Thesis, Erasmus University, pp. 149–64.
Arthritis Rheum 33:525–32. 59. Heliovaara, M., Mkel, M., and Impivaara, O., et al. (1993). Association of
36. Wolfe, F., Altman, R., Hochberg, M., Lane, N., Luggan, M., and Sharp, J. overweight, trauma and workload with coxarthrosis: a health survey of 7,217
(1994). Postmenopausal estrogen therapy is associated with improved radi- persons. Acta Orthop Scand 64:513–18.
ographic scores in OA and RA. Arthritis Rheum 37(Suppl.):S231. 60. Carman, W.J., Sowers, M.F., Hawthorne, V.M., and Weissfeld, L.A. (1994).
37. Zhang, Y, McAlindon, T.E., Hannan, M.T., et al. (1998). Estrogen replace- Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective
ment therapy and worsening of radiographic knee osteoarthritis. Arthritis study. Am J Epidemiol 39:119–29.
Rheum 41:1867–73. 61. Hannan, M.T., Anderson, J.J., Zhang, Y., Levy, D., and Felson, D.T. (1993).
38. Hart, D.J., Doyle, D.V., and Spector, T.D. (1999). Incidence and risk factors Bone mineral density and knee osteoarthritis in elderly men and women: the
for radiographic knee osteoarthritis in middle-aged women: the Chingford Framingham Study. Arthritis Rheum 36:1671–80.
Study. Arthritis Rheum 42:17–24. 62. *Felson, D.T., Zhang, Y., Anthony, J.M., Naimark, A., and Anderson, J.J.
39. Wluka, A.E., Davis, S.R., Bailey, M., Stuckey, S.L., and Cicuttini, F.M. (1992). Weight loss reduces the risk for symptomatic knee osteoarthritis in
(2001). Users of oestrogen replacement therapy have more knee cartilage women. Ann Intern Med 116:535–9.
than non-users. Ann Rheum Dis 60:332–6. Longitudinal study of women suggesting that weight 12 years prior to onset
40. Sandmark, H., Hogstedt, C., Lewold, S., and Vingard, E. (1999). Osteoarthrosis of symptomatic OA increases risk, and that modest weight loss (approximately
of the knee in men and women in association with overweight, smoking, and 12 lbs) can dramatically lower the risk of developing disease, especially among
hormone therapy. Ann Rheum Dis 58:151–5. those who are overweight at baseline.
41. Nevitt, M.C., Felson, D.T., Williams, E.N., and Grady, D. (for the Heart and 63. Schouten, J.S.A.G., van den Ouweland, and Valkenburg, H.A. (1992).
Estrogen/Progestin Replacement Study Research Group) (2001). The effect A 12-year follow-up study in the general population on prognostic factors of
of estrogen plus progestin on knee symptoms and related disability in post- cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 51:932–7.
menopausal women. Arthritis Rheum 44:811–8. 64. *Felson, D.T. and Zhang, Y.Q. (1998). An update on the epidemiology of
42. *McAlindon, T.E., Felson, D.T., Zhang, Y., et al. (1996). Relation of dietary knee and hip osteoarthritis with a view to prevention. Arthritis Rheum
intake and serum levels of Vitamin D to progression of osteoarthritis of the 41:1343–55.
knee among participants in the Framingham Study. Ann Intern Med A comprehensive recent review of disease epidemiology including data on
125:353–9. prevalence of disease in knee and hip and a critical review of current thinking
A longitudinal study suggesting that low 25-OH vitamin D levels increase about risk factors.
the risk of progressive radiographic knee OA. 65. Schouten, J.S.A.G., van den Ouweland, and Valkenburg, H.A. (1992).
43. Lane, N.E., Gore, L.R., Cummings, S.R., et al. (1999). Serum vitamin D A 12-year follow-up study in the general population on prognostic factors of
levels and incident changes of radiographic hip osteoarthritis. Arthritis cartilage loss in osteoarthritis of the knee. Ann Rheum Dis 51:932–7.
Rheum 42:854–60. 66. Dougados, M., Gueguen, A., Nguyen, M., et al. (1992). Longitudinal radio-
44. Kellgren, J.H. (1961). Osteoarthritis in patients and populations. Br Med J logic evaluation of osteoarthritis of the knee. J Rheumatol 19:378–83.
243:1–6. 67. Altman, R.D., Fried, J.F., Bloch, D.A., et al. (1987). Radiographic assessment
45. Solomon, L. (1976). Patterns of osteoarthritis of the hip. J Bone Joint Surg of progression in osteoarthritis. Arthritis Rheum 30:1214–25.
58(B):176–83. 68. Spector, T.D., Hart, D.J., and Doyle, D.V. (1994). Incidence and progression
46. Lane, N.E., Lin, P., Christiansen, L., et al. (2000). Association of mild acetab- of osteoarthritis in women with unilateral knee disease in the general popu-
ular dysplasia with an increased risk of incident hip osteoarthritis in elderly lation: the effect of obesity. Ann Rheum Dis 53:565–8.
white women. Arthritis Rheum 43:400–4. 69. McGoey, B.V., Deitel, M., Saplys, R.J.F., and Kliman, M.E. (1990). Effect of
47. Jacobsen, K. (1977). Osteoarthrosis following insufficiency of the cruciate weight loss on musculoskeletal pain in the morbidly obese. J Bone Joint Surg
ligaments in man. Acta Orthop Scand 48:520–6. 72(B):322–3.
48. Roos, H.P., Lauren, M., Adalberth, T., Roos, E.M., Jonsson, K., and 70. Williams, R.A. and Foulsham, B.M. (1981). Weight reduction in osteoarthri-
Lohmander, L.S. (1998). Knee osteoarthritis after meniscectomy. Arthritis tis using phentermine. The Practitioner 225:231–2.
Rheum 41:687–93. 71. Slemenda, C., Brandt, K.D., Heilman, et al. (1997). Quadriceps weakness
49. Roos, H.P., Ostenberg, A. (2000). A prospective study of female soccer and osteoarthritis of the knee. Ann Intern Med 127:97–104.
players with anterior cruciate ligament tear. Radiographic findings and 72. Madsen, O.R., Bliddal, H., Egsmose, C., and Sylvest, J. (1995). Isometric and
symptoms 12 years after injury. Arthritis Rheum 43:913. isokinetic quadriceps strength in gonarthrosis; inter-relations between
50. Felson, D.T. (1990). The epidemiology of knee osteoarthritis: results quadriceps strength, walking ability, radiology, subchondral bone density
from the Framingham osteoarthritis study. Sem Arthritis Rheum 20: 42–50. and pain. Clin Rheumatol 14:308–14.
16 2
73. *Slemenda, C., Heilman, D.K., Brandt, K.D., et al. (1998). Reduced quadri- 85. Spector, T.D., Harris, P.A., Hart, D.J., et al. (1996). Risk of osteoarthritis asso-
ceps strength relative to body weight. A risk factor for knee osteoarthritis in ciated with long-term weight-bearing sports. Arthritis Rheum 39:988–95.
women? Arthritis Rheum 41:1951–9. 86. McDermott, M. and Freyne, P. (1983). Osteoarthrosis in runners with knee
Compared to women who did not get OA, those who developed incident pain. Br J Sports Med 17:84–7.
radiographic OA had weaker quadriceps 3 years earlier. No association of 87. Kujala, U.M., Kettunen, J., Paananen, H., et al. (1995). Knee osteoarthritis in
quadriceps weakness with incident OA was found in men. former runners, soccer players, weight lifters, and shooters. Arthritis Rheum
74. Jefferson, R.J., Collins, J.J., Whittle, M.W., Radin, E.L., and O’Connor, J.J. 38:539–46.
(1990). The role of the quadriceps in controlling impulsive forces around 88. Lane, N.E., Hochberg, M.C., Pressman, A., Scott, J.C., and Nevitt, M.C.
heel strike. Proc Instn Mech Engrs 204:21–8. (1999). Recreational physical activity and the risk of osteoarthritis of the hip
75. Chaisson, C.E., Zhang, Y., Sharma, L., Kannel, W., Felson, D.T. (1999). Grip in elderly women. J Rheumatol 26:849–540.
strength and the risk of developing radiographic hand osteoarthritis: results 89. Manninen, P., Riihimaki, H., Heliovaara, M., Suomalainen, O. (2001).
from the Framingham study. Arthritis Rheum 42:33–8. Physical exercise and risk of severe knee osteoarthritis requiring arthro-
76. Croft, P., Coggon, D., Cruddas, M., and Cooper, C. (1992). Osteoarthritis of plasty. Rheumatology 40:432–7.
the hip: an occupational disease in farmers. Br Med J 304:1269–72. 90. McAlindon, T.E., Wilson, W.F., Aliabadi, P., Weissman, B., Felson, D.T.
77. Kellgren, J.H. and Lawrence, J.S. (1952). Rheumatism in miners. II: X-ray (1999). Level of physical activity and the risk of radiographic and sympto-
study. Br J Ind Med 9:197–207. matic knee osteoarthritis in the elderly: the Framingham study. Am J Med
78. Lawrence, J.S. (1961). Rheumatism in cotton operatives. Br J Ind Med 106:151–7.
18:270–6. 91. Felson, D.T., Chaisson, C.E., Hill, C.L., et al. (2001). The association of
79. Hadler, N.M., Gillings, D.B., Imbus, R. et al. (1978). Hand structure and bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med
function in an industrial setting. Arthritis Rheum 21:210–20. 134:541–9.
80. Anderson, J. and Felson, D.T. (1988). Factors associated with osteoarthritis 92. *Hill, C.L., Gale, D.G., Chaisson, C.E., et al. (2001) Knee effusions, popliteal
of the knee in the First National Health and Nutrition Examination Survey cysts and synovial thickening: association with knee pain in those with and
(NHANES I). Am J Epidemiol 128:179–89. without osteoarthritis. J Rheumatol 28:1330–7.
81. Kujala, U.M., Kettunen, J., Paananen, H., et al. (1995). Knee osteoarthritis in Compared to persons without knee pain, those with knee pain more often
former runners, soccer players, weight lifters and shooters. Arthritis Rheum had synovitis and effusions on their knee MRI’s. Prior reference (Felson et al.)
38:539–46. suggested that also those with knee pain more often had bone marrow edema
82. Felson, D.T., Hannan, M.T., Naimark, A., et al. (1991). Occupational phys- lesions. These two studies provide evidence that bone marrow edema, synovitis,
ical demands, knee bending, and knee osteoarthritis: results from the and effusions are the structural findings correlated with knee pain in OA.
Framingham Study. J Rheumatol 18:1587–92. 93. Oliveria, S.A., Felson, D.T., Reed, J.I., Cirillo, P.A., and Walker, A.M. (1995).
83. Cooper, C., McAlindon, T., Coggon, D., Egger, P., and Dieppe, P. (1994). Incidence of symptomatic hand, hip, and knee osteoarthritis among patients
Occupational activity and osteoarthritis of the knee. Ann Rheum Dis 53:90–3. in a health maintenance organization. Arthritis Rheum 38:1134–41.
84. Anderson, J., and Felson, D.T. (1988). Factors associated with osteoarthritis 94. Cooper, C., McAlindon, T.E., Goggon, D., Egger, P., and Dieppe, P. (1994).
of the knee in the First National Health and Nutrition Examination Survey Occupational activity and osteoarthritis of the knee. Ann Rheum Dis
(NHANES I). Am J Epidemiol 128:179–89. 53:90–3.
3 The economics of osteoarthritis
Edward Yelin
Demographers and economists traditionally divide chronic diseases into Kingdom have recently been completed. Table 3.1 summarizes the results of
two groups: those of high prevalence and low-average impact, for example, these studies. In the first systematic study of the cost of illness, Rice10
chronic sinusitis; and those of low prevalence and high-average impact, for reported that in the United States of America in 1963, musculoskeletal con-
example, systemic lupus erythematosus.1 OA sits astride these two major ditions accounted for $4 billion in total costs, half of which was attributed
classifications: it is clearly a high prevalence condition, but it must also be to the direct costs of medical care and the other half to wage losses and
classified as one with at least a moderate, if not a high level of impact. More the imputed value of homemaker losses. This sum was equivalent to 0.7 per
importantly, because OA is associated with age,2 the aging of the population cent of the gross national product (GNP).
puts a higher proportion of the total population at risk for OA. Moreover, The relative magnitude of the total costs of musculoskeletal disease in the
the aging of the population puts a higher proportion of persons with OA in United States of America remained fairly stable through 1980, though the
the age groups in which the severity of the disease is greatest. This combin- proportion due to medical care and wage losses changed substantially.14,15
ation of high and growing prevalence, and moderate to severe impact, In the 1960s, real wages were rising rapidly, while medical care inflation had
makes OA an important condition in health policy concerns. not yet become a significant problem. Accordingly, the proportion of total
Interestingly, the condition has received relatively scant attention in costs due to lost wages rose between the 1963 and 1972 studies. In contrast,
the cost-of-illness literature. Instead, health services researchers from the after the oil shock of the early 1970s, real wages stagnated while medical
rheumatology community have focussed on the cost of rheumatoid arthri- care prices rose quickly. By 1980, direct costs of musculoskeletal disease
tis (RA) in clinical samples, probably because it is a more prominent con- accounted for more than 60 per cent of the total costs of this group of
dition in the practices of rheumatologists.3–9 On the other hand, in their illnesses. However, by 1988, total costs had increased to $124 billion, with
own studies, demographers and economists tend to focus on the more more than half associated with indirect costs.16
encompassing rubrics of musculoskeletal disease or all forms of arthritis, The most recent national study of the costs of musculoskeletal conditions
probably because the data sets they analyse do not include discrete diag- concerned 1995.17 In that year, the total costs of these illnesses amounted to
noses, such as OA. However, persons with OA constitute a large fraction $215 billion, or about 2.9 per cent of the GNP. Less than half of the total was
of all persons with musculoskeletal conditions and, therefore, of the costs due to direct costs of medical care; the balance was due to wage losses. In the
of these diseases. same study, the cost of arthritis alone was estimated to be $83 billion, with
This chapter reviews the studies of the economic impact of muscu- about three-quarters of that total due to lost wages.
loskeletal disease and all forms of arthritis, in general, conducted on random These studies of the national economic impact of musculoskeletal condi-
samples of the population; summarizes the small literature on the cost of tions in the United States of America suggest a large increase in costs
OA, in particular, based on clinical samples, including those conducted in occurred between 1980 and 1988, differences among the studies in methods
managed care environments in the United States of America; compares notwithstanding.18
results from clinical studies of OA and RA; and then uses the 1979–81 The relative magnitude of the costs of musculoskeletal conditions in
National Health Interview Survey to make preliminary estimates of the Canada, Australia, and the United Kingdom would appear to be similar to
absolute national cost of arthritis and of the increment in costs experienced that in the United States of America.19–22 For example, in 1986 the total
by persons with arthritis compared to those of similar age, sex, and race costs of musculoskeletal conditions in Canada was approximately 1.7 per
without arthritis. The pharmacoeconomics of treatment of OA are discussed cent of the GNP, or about half-way between the estimates for the United
specifically in Chapter 8. States of America for 1988 of the costs of all forms of arthritis alone and all
forms of musculoskeletal disease. In addition to the studies of all forms of
musculoskeletal conditions in various nations, a study has been published
Cost-of-illness studies concerning the costs of OA, in particular, in France; total costs of OA were
approximately 6 billion francs per year.22
The costs of illness are divided into two distinct spheres, those due to direct
expenditures for medical care services and those due to the indirect impact
of illness on function, principally measured by lost wages due to reduced Costs of osteoarthritis from studies using
work effort or total cessation of work activities.10–13
clinical samples
National studies of the cost of Only four studies of the costs of osteoarthritis have been derived from clin-
ical samples and in only one of these was indirect cost due to lost wages
musculoskeletal diseases assessed. Table 3.2 summarizes the result of these studies, expressing all costs
Five studies of the cost of musculoskeletal diseases in the United States of in 1999 terms. The study by Liang et al.25 derives from a random sample of
America have been published, the two most recent of which presented those who had ever attended a tertiary care facility. They reported that physi-
the costs of arthritis separately. In addition, studies of the economic impact cian visits accounted for only a small portion of direct costs of medical care;
of musculoskeletal disease in Canada, Australia, France, and the United the majority of direct costs were due to a handful of hospital admissions and
18 3
Table 3.1 Cost of musculoskeletal diseases in the current US, Canadian, and Australian dollars, French francs, and British pounds and as a % of
Gross National Product (GNP)
Source: US, Refs 10, 14–17; Canada, Ref. 19; Australia, Ref. 20; United Kingdom, Ref. 21; France, Ref. 22. Adopted from Ref. 23.
Table 3.2 Costs of osteoarthritis, in 1999 dollars, from four studies using clinical samples
Notes: All costs have been expressed in 1999 terms by inflating study year costs by the change in the Consumer Price Index (24, p. 487). In the study by Liang et al.,25 indirect costs were estimated
jointly for persons with OA and RA; this amount was applied here for the persons with OA. In the study by Holman et al.,26 neither ‘other’ costs nor indirect costs were reported. The study by
Gabriel et al.27 reported the frequency of changes in employment, but not the associated indirect costs. Lanes et al.28 reported costs incurred by a member of a health maintenance organization.
to the category ‘other’, which include prescription and non-prescription a true population-based study, with the caveat that those who have OA
drugs and medical devices. Indirect costs of OA dwarfed medical costs, aver- but have not received a diagnosis would not appear in the database. In
aging $12 032 in 1999 terms among all persons with OA. this study, the authors did not report direct medical costs by category.
The study by Holman et al.26 was limited to costs of physician visits and Moreover, they accounted only for costs that generated medical bills.
hospital admissions. It was conducted in Northern California and included Nonetheless, their estimate of overall annual direct medical care costs for
respondents receiving care in the fee-for-service sector, in a pre-paid group OA—$2427 per person in 1999 terms—exceeds the estimates from the two
practice, and in an experimental center designed to lower utilization rates. previous studies. Although Gabriel et al. did not estimate the wage losses
The authors reported that the magnitude of the costs of hospitalization in associated with OA, they noted that about 11 per cent of persons with OA
their study was similar to that in the study by Liang et al., but they also reduced their hours of work, 9 per cent reported being unable to get a job,
reported much higher costs due to physician visits, and overall direct med- and 14 per cent retired early due to this condition.
ical care costs more than 20 per cent higher, even though the costs of drugs In another study using a clinical sample, Lanes et al.28 analysed costs
and devices were not estimated. Interestingly, costs were lower in the experi- among members of a single health maintenance organization, and found
mental setting than in the pre-paid group practice, and lower in the pre- costs to be considerably lower than other studies (direct costs totalled only
paid group practice than under fee-for-service. This suggests that medical $611 in 1999 terms), perhaps indicating lower costs in that form of man-
care costs of OA can be reduced through both financial incentives to aged-care organization than in other systems of care.
providers and patients and through non-monetary incentives in a practice
designed to reduce utilization through more interactive relationships
between patients and physicians. Comparison of the costs of OA and RA
Gabriel et al.27 assembled a database of all persons with a diagnosis of OA Table 3.3 compares the per-case costs of OA and RA by averaging values
among residents of Olmstead County, Minnesota. This sample approximates from each of the studies using clinical samples (two values are provided for
3 19
Table 3.3 Costs, in 1999 dollars, of rheumatoid arthritis and osteoarthritis from average of clinical studies
Study Physician Hospital Other Total Direct Costs Indirect Costs Total
OA-including Lanes et al. 537 585 577 1699 12 032 13 731
OA-excluding Lanes et al. 738 737 958 2433 12 032 14 465
RA 1082 3361 1397 5840 18 907 24 747
Notes: All costs have been expressed in 1999 terms by inflating study year costs by the change in the Consumer Price Index (32, p. 487). The first estimate of the costs of OA was obtained by
averaging the four studies summarized in Table 3.2, or, where only one study provided as estimate, using that one value. The second estimate of the costs of OA excludes the value from the
study of Lanes et al.28 because the latter study is an outlier among the four studies. The costs of RA were estimated in a fashion similar to that for the OA estimates, using the studies of Meenan
et al.3 and Lubeck et al.4
OA, including and excluding the study by Lanes et al. because the costs in Table 3.4 Per capita and total utilization of persons reporting arthritis,
that study appear to be systematically lower than those in the other three US, 1989–91
studies). Not surprisingly, the per-case costs of RA exceed the costs of OA
in every category, with the costs of hospital admissions accounting for Type of utilization Mean Total
the largest relative difference. Overall, the per-case cost of RA is more than (millions)
1.7 times as great as the per-case cost of OA, even if the results of Lanes et al. Visits to physicians 7.34 226.3
are excluded. Nevertheless, because the prevalence of OA is so great, OA has
Hospital admissions 0.22 6.9
a far greater overall impact on the economy than RA. Assuming a liberal
estimate of the prevalence of RA of 1.0 per cent of the total population, a Hospital days 1.58 48.8
conservative estimate of the prevalence of OA of 4.2 per cent of males and Length of admissions (in days) 7.07
9.0 per cent of females 20 years of age or over;2 estimates of the per-case cost
Source and note: Author’s analysis of 1989–91 National Health Interview Surveys.
of OA, including those from Lanes et al.; and the US population in 1999,24 Estimates based on averaging across the three surveys.
there are 2.73 million persons with RA and 13.03 million with OA in the
nation. Accordingly, the total costs of OA, at $178.9 billion, are about
2.65 times as large as the total costs of RA, at $67.5 billion. Even using the
highest published estimates for the prevalence of RA—2 per cent,2 the These hospital admissions totaled 48.8 million days; the average length of
national cost of OA would still exceed the national cost of RA by about stay was 7.07 days per admission.
50 per cent. It should be noted that the combined cost of OA and RA— Table 3.5 provides estimates of the economic impact of this medical care
about $246 billion—is far larger than the most recent estimate of the utilization and of the wage losses associated with arthritis. These estimates
cost of all forms of arthritis from a US national study in 1995,18 $83 billion, were made by multiplying the number of units of physician visits used
or about $91 billion in 1999 terms (Table 3.1). The higher estimate from the by $90 (the approximate average of the costs of a physician visit in
clinical samples may be due to the greater severity of the disease among per- the nation in 1999), and the number of hospital admissions by $8220 (the
sons sampled in clinical environments. Alternatively, the difference may be average cost of all hospital stays in the United States of America in that
due to the greater level of detail in the enumeration of costs in the clinical year). Using these unit prices, all persons self-reporting arthritis incurred
studies. $2.0 billion in costs due to physician visits and $56.7 billion in costs due to
hospital admissions in the years 1989–91. Because many of the hospital
National community-based estimates of admissions for arthritis include surgical procedures, including total joint
replacement surgery, and surgical admissions are more expensive than this
the impact of arthritis average, the ‘true’ cost of the admissions probably exceeds the $56.7 billion
In studies using clinical samples, researchers are able to customize data col- estimate. Even without adjusting the unit price of hospital admissions to
lection to ensure relatively complete enumeration of the impacts of illness. take surgery into account, the annual cost of medical care for arthritis is at
However, the sample of persons with the illness is biased, either because least $58.7 billion. Including the costs of drugs and devices, which are not
those who receive a diagnosis may have inherently better access to care, or enumerated in the HIS, would substantially increase this total.
because they may have more severe illness than those who do not. In addition, 14.1 per cent fewer of those with arthritis are in the labor
In part, to avoid the bias from sampling in clinical environments, the force than persons without arthritis. Thus, 2.34 million persons with
federal government in the United States of America instituted an annual arthritis were not working who would have been working if they had the
community-based survey of the health of the population—the National same labor force participation rates as persons without arthritis. If a unit
Health Interview (HIS).29 In the HIS, individuals self-report their symp- price for wage losses, based on average earnings among all US workers in
toms and, unless a physician has told the individual a specific diagnosis 1999, is applied, the indirect costs of arthritis total at least $66.8 billion.
associated with the symptoms, a general diagnostic code, such as arthritis, This figure omits all losses due to reduction in hours worked or the lesser
is given. The analysis reported below provides estimates of the impact of degree of career advancement experienced by persons with arthritis in
all forms of self-reported arthritis for the years 1989–91 (using three years comparison with those without arthritis.
reduces the sampling variability associated with any one year’s data). OA Even though the estimate of the direct costs omits common expenses
accounts for most of the subjects in this diagnostic classification.30 for arthritis, and the estimate of indirect costs omits partial work disability,
Over the period 1989–91, an average of 30.8 million individuals report- the estimate of the total cost of arthritis—$125.5 billion—represents
ed symptoms consistent with arthritis, providing an overall prevalence rate 1.4 per cent of the gross domestic product for the United States of America
of 12.3 per cent, that is, roughly twice the rate that has been estimated from for the year 1999.24
epidemiological studies of OA based on physician examination.2 Table 3.4 Table 3.5 provides estimates of the total costs incurred by persons with
summarizes the average and total health care utilization of these individu- arthritis. Table 3.6, in contrast, shows the increment in costs experienced by
als self-reporting arthritis. Overall, they made a mean of 7.34 visits to persons with arthritis relative to the remainder of the population and
physicians in the year prior to the interview, or 226.3 million visits overall. assuming persons with arthritis have the same age, race, and sex distribu-
In addition, they experienced an average of 0.22 hospital admissions per tion as those without arthritis. Persons with arthritis make slightly less than
person, amounting to 6.9 million admissions in the nation as a whole. one more visit per physician year than similar persons without arthritis.
20 3
Table 3.5 Estimates of the absolute national costs of arthritis in 1999, US, 1989–91
Direct costs
Physician visits Hospital admissions Total
Number Unit price Total Number Unit price* Total
226.3 mil $90 $2.0 bil 6.9 mil $8220 $56.7 bil $58.7 bil
Indirect costs
Number leaving work† Unit price‡ Total Total costs
2.34 mil $28,548 $66.8 bil $125.5 bil
Source and notes: Author’s analysis of 1989–91 National Health Interview Surveys.
* Unit price of hospital admission based on average cost of patient stay in US short-term hospitals in 1992 (33, p. 127), with the value inflated to 1999 terms using the Medical Care
Component of the Consumer Price Index (24, p. 487).
† Number of persons who left work based on difference in age, sex, and race matched labor force participation rates of persons without arthritis and actual labor force participation rate of
persons with arthritis (14.1%).
‡ Unit price of cessation of work based on the US median weekly wage times 52 weeks (24, p. 437).
Table 3.6 Estimates of the incremental national costs of arthritis in 1994, US, 1989–91
Direct costs
Physician visits Hospital admissions Total
Incremental# Unit price Total Incremental* Unit price# Total
0.98 mil $90 $0.1 bil 0.06 mil $8220 $0.5 bil $0.6 bil
Indirect costs
Incremental# Leaving work† Unit price‡ Total Total costs
1.00 mil $28,548 $28.6 bil $29.2 bil
Source and notes: Author’s analysis of 1989–91 National Health Interview Surveys.
* Incremental number of physician visits and hospital admissions per person based on regressions estimating the utilization among persons with OA assuming the age, sex, and race distribu-
tion in the remainder of the population.
# Unit price of hospital admission based on average cost of patient stay in US short-term hospitals in 1992 (31, p. 127), with this value inflated to 1999 terms using the Medical Care
Component of the Consumer Price Index (24, p. 487).
† Number of persons who left work based on difference in labor force participation of persons without arthritis, and the estimated labor force participation rate of persons with arthritis and
the same distribution of age, sex, and race as persons without arthritis (6.0%).
‡ Unit price of cessation of work based on the US median weekly wage times 52 weeks (24, p. 437).
Accordingly, the incremental costs of their physician visits are relatively account for a large proportion of the increment in costs attributable to
small—$0.1 billion. The incremental cost of their hospitalizations is much hospitalization.32 To an even greater extent, policymakers would do well
larger: based on an excess of 0.06 admissions per capita and a unit cost of to emphasize the impact of arthritis on work, since wage losses account for
$8220 per admission, the increment in the costs of the hospital admissions almost two-thirds of the incremental cost of arthritis.
of persons with arthritis is $0.5 billion. Thus, of the total incremental med-
ical care costs of $0.6 billion incurred by persons with arthritis, more than
80 per cent is due to excess hospital admissions.
However, the incremental costs of wage losses dwarf even those due to Summary and conclusions
hospitalization. In the period 1989–91, an extra 1.0 million persons with In contrast to RA, the cost of OA has been the subject of few studies. From
arthritis were out of work, relative to the expected labor force participation these studies, the annual cost of OA would appear to be in the range of from
rate of persons with the same age, sex, and race characteristics but without $13 000–15 000 per case, with most of the costs due to lost wages. Though its
arthritis. After multiplying this number by the average wages of US work- per-case cost is lower than that of RA, because of the much greater preval-
ers, the increment in wage losses totals $28.6 billion. All told, the increment ence of OA, the overall economic impact of OA is much greater. However, it
in wage losses of persons with arthritis relative to those without is far larg- is very difficult to provide a good estimate of the exact magnitude of the eco-
er than the increment in direct medical care costs. nomic cost of OA for the nation. In self-report studies, such as the HIS, the
Policymakers concerned about the medical care costs of arthritis would prevalence of OA is under-reported; most OA is classified under the more
do well to focus on reducing hospital admissions, since excess admissions are encompassing rubric of ‘all forms of arthritis’. Indeed, a diagnosis of OA
responsible for the bulk of the increment in medical care costs. Although occurs relatively infrequently in the clinical environment, because physicians
one cannot easily attribute surgical procedures to particular conditions often do not differentiate among musculoskeletal complaints in their treat-
in the HIS, we know from other sources of data that surgical admissions ment plans. As shown above, it can be estimated that the economic impact of
3 21
this more encompassing rubric is $125.5 billion, and that people with arthri- 11. Walker, K. and Gauger, W. (1970, revised 1980). The dollar value of house-
tis incur incremental costs of about $29.2 billion, mostly due to lost wages. hold work. In Information Bulletin, No. 60. Ithaca, New York: New York State
The estimates of the per-case cost and of the national impact must both be College of Human Ecology.
viewed as preliminary, however, in the former case because the clinical stud- 12. Lubeck, D. and Yelin, E. (1988). A question of value: measuring the impact
ies are few and not as systematic as studies of the cost of RA and in the of chronic disease. Milbank Quart 66:445–64.
latter case because of the lack of differentiation of OA from other forms of 13. Reisine, S., Goodenow, C., and Grady, K. (1987). The impact of rheumatoid
musculoskeletal disease in the relevant databases. arthritis on the Homemaker. Soc Sci Med 25:89–95.
However, to a certain extent these shortcomings in the literature reflect a 14. Cooper, B. and Rice, D. (1976). The economic cost of illness revisited. Soc
shortcoming of concern about OA itself. Even these preliminary findings Sec Bull 39:21–35.
should indicate to policymakers that the combination of high prevalence, 15. Rice, D., Hodgson, T., and Kopstein, A. (1985). The economic costs of ill-
and moderate to high impact, combine to make OA a costly illness. It is ness: a replication and update. Health Care Finance Rev 7:61–80.
time to conduct more systematic studies on the economic impact of OA, so 16. *Rice, D. (1992). Cost of musculoskeletal conditions. In A. Pramer,
that we can plan adequately for the pandemic of OA we face with the aging S. Furner, and D. Rice (eds.) Musculoskeletal Conditions in the US. Chicago:
of the population. American Academy of Orthopedics, pp. 143–70.
This article documents the high toll that all forms of musculoskeletal disease,
but especially arthritis, played in the national economy in the early 1990s.
Key points Using methods from prior studies, the author shows that the impact of these
conditions has grown dramatically because of the aging of the population.
1. Musculoskeletal conditions account for as much as 1.1–2.9 per cent 17. Rice, D. (1999). Cost of musculoskeletal conditions. In A. Pramer, S. Furner,
of the GNP of nations with advanced economies, including the and D. Rice (eds.) Musculoskeletal conditions in the US (2nd ed.), Chigaco:
direct costs associated with medical care and the indirect costs due American Academy of Orthopedics, pp. 141–62.
to lost function and work disability. 18. *Yelin, E. and Callahan, L. (1995). The economic cost and social and psy-
chological impact of musculoskeletal conditions. Arthritis Rheum
2. All forms of arthritis account for as much as 1.2 per cent of the GDP
38:1351–62.
of the United States of America.
This article, written by members of the National Arthritis Data Task Force, is
3. The direct cost of OA averages between $1699 and 2433, while indi- a comprehensive review of the literature on the economic costs and psychologi-
rect costs are $12 032, in 1999 terms. cal impact of musculoskeletal conditions. It can be used to access the key articles
4. Even though the per-case cost of RA is higher than that of OA because in the cost of arthritis literature.
of the much higher prevalence of OA, the total costs of OA—$178.9 19. Badley, E. (1995). The economic burden of musculoskeletal disorders in
billion in 1999 terms—exceed those of RA by at least 50 per cent. Canada is similar to that for cancer, and may be higher. J Rheumatol 22:204–6.
20. Arthritis Foundation of Australia. (1994). In Industry Commission Report.
5. Most of the increment in costs of arthritis beyond that expected of Cost of Arthritis to the Australian Community, pp. 14–22.
persons of similar age and gender is due to work loss, not to expen- 21. Freedman, D. (1989). Arthritis: the painful challenge, Searle Social Research
ditures for medical care. Fellowship Report.
22. Levy, E., Ferme, A., Perocheau, D., and Bono, I. (1993). Les couts socio-
economiques de l’arthrose en France. Rev Rheum 60:63s–67s.
References 23. March, L. and Bachmeier, C. (1997). Economics of osteoarthritis: a global
(An asterisk denotes recommended reading.) perspective. Bailliere’s Clin Rheum 11:817–34.
1. *Verbrugge, L. and Patrick, D. (1995). Seven chronic conditions: their 24. USGPO. (2000). Statistical Abstract of the US, 2000, p. 13, 127, 437, 487.
impact on US adults’ activity levels and use of medical services. Am J Public 25. Liang, M., Larson, M., Thompson, M., Eaton, H., McNamera, E., and
Health 85:173–82. Katz, R., et al. (1984). Costs and outcomes in rheumatoid and osteoarthritis.
This article shows the differential impact of various chronic conditions on Arthritis Rheum 27:522–9.
disability and access to medical care. It demonstrates that arthritis is among the
26. Holman, H., Lubeck, D., Dutton, D., and Brown, B. (1988). Improving
leading causes of disability, starting in middle age, but is not among the leading
health service performance by modifying medical practices. Trans Assoc Am
reasons for physician visits or hospital admissions in any age group.
Phys 101:173–9.
2. Silman, A. and Hochberg, M. (1993). In Epidemiology of the rheumatic
27. *Gabriel, S., Crowson, C., and O’Fallon, W. (1995). Costs of osteoarthritis:
diseases. Oxford: Oxford University Press, pp. 257–88.
estimates from a geographically defined population. J Rheumatol 22(Suppl.
3. Meenan, R., Yelin, E., Henke, C., Curtis, D., and Epstein, W. (1978). The 43):23–5.
costs of rheumatoid arthritis. Arthritis Rheum 21:827–33. This article is unique among studies of the costs of arthritis because of the
4. Lubeck, D., Spitz, P., Fries, J., Wolfe, F., Mitchell, D., and Roth, S. (1986). combination of the community-based sampling frame and certainty of diagnosis
A multicenter study of annual health services utilization and costs in rheuma- provided by a database of all medical care encounters in the area surrounding
toid arthritis. Arthritis Rheum 29:488–93. Rochester, Minnesota.
5. Thompson, M., Read, J., and Liang, M. (1984). Feasibility of willingness-to- 28. *Lanes, S., Lanza, L., Randensky, P., Yood, R., Meenan, R., Walker, A., and
pay measurements in chronic arthritis. Med Decis Making 4:195–212. Dreyer, N. (1997). Resource utilization and cost of care for rheumatoid
6. Stone, C. (1984). The lifetime costs of rheumatoid arthritis. J Rheumatol arthritis and osteoarthritis in a managed care setting. Arthritis Rheum
11:819–27. 40:1475–81.
7. Pugner, K., Scott, D., Holmes, J., and Hieke, K. (2000). The costs of rheuma- This article provided the first indication of the extent of the medical care
toid arthritis: an international long-term view. Sem Arthritis Rheum utilization and economic costs for RA in a closed-system sample, that is, in a
29:305–20. managed care organization.
8. Albers, J., Kuper, H., van Riel, P., Prevoo, M., Van’t Hof, M., van Gestel, A., 29. Kovar, M. and Poe, G. (1985). National Health Interview Survey design,
and Severens, J. (1999). Socio-economic consequences of rheumatoid 1973–84 and procedures, 1975–83. Vital Health Stat 18 (Series 1):1–130.
arthritis in the first years of the disease. Rheumatology 38:423–30. 30. LaPlante, M. (1988). Data on disability from the National Health Interview
9. Merkesdal, S., Ruof, J., Schoofski, O., Bernitt, K., Zeidler, H., and Mau, W. Survey, National Institute on Disability and Rehabilitation Research,
(2001). Indirect costs in early rheumatoid arthritis. Arthritis Rheum Washington, DC.
44:528–34. 31. USGPO (1994). Statistical Abstract of the US, 1994, p. 127.
10. Rice, D. (1966). Estimating the cost of illness. Health Econ Ser, No. 6, 32. Felts, W. and Yelin, E. (1989). The economic impact of the rheumatic
National Center for Health Statistics. diseases in the United States. J Rheumatol 16:867–84.
This page intentionally left blank
4
Genetic aspects of
osteoarthritis
Genetic studies are under way for many complex traits, spurred by the hereditary factors. Other earlier clinical studies by Kellgren and associates6
improvement in genetic tools and resources during the past decade. The and Lawrence and Moore7 on generalized OA and other OA subtypes, sug-
mechanism by which DNA sequence variations or alleles in genes con- gested that specific forms of common OA cluster within families. A retro-
tribute to differences within the human population with respect to the spective radiographic analysis of hip OA by Lindberg provided further
occurrence of OA is unknown. support for this observation.8 In this study, siblings of patients who had
Epidemiological studies have provided evidence to support the long- undergone hip replacement were noted to have twice the incidence of hip
standing clinical perspective that environmental factors predominate in the OA than that of age- and sex-matched control subjects. Chitnavis et al.9
etiology of OA. Important risk factors affecting disease status include age, have estimated the relative risks of advanced, symptomatic OA of the hip
occupation, body mass index, trauma, and joint deformity.1 Conversely, and knee in siblings of probands having total joint replacement for OA.
genetic liability is traditionally seen to predominate in only a small minor- Spouse-based controls were used to correct for environmental influences. A
ity of the OA population. Families that transmit OA as a simple Mendelian sibling relative risk of 1.9 for total hip replacement and 4.8 for total knee
genetic trait have been described but are rare. Partitioning OA into these replacement was calculated. The overall combined relative risk for joint
two conceptual groups, that is, strongly genetic or strongly environmental, replacement was 2.3. A sibling study by Lanyon and colleagues10 showed
neglects the majority of the population in which the interplay between that siblings of patients with hip OA of sufficient severity to warrant total
genes and environment in the occurrence of ‘common’ OA remains hip replacement have a high risk of radiographic hip OA. Each study,
significant. despite using different approaches, demonstrates that relatives of affected
To study sources of individual differences (i.e., the variance) in a pheno- individuals have higher rates of OA than the general population. Table 4.1
type such as OA, genetically related subjects are required and methods of summarizes these trials. Clustering of OA within families is suggestive of a
assessing genetic influence in common OA include estimations of relative genetic contribution to common OA, but they do not provide conclusive
risk such as sibling recurrence risk (s). This is an estimate of familiality or evidence. Clearly, familial aggregation of disease might also be explained by
the risk of disease in first-degree relatives of the patients affected with OA non-genetic factors owing to siblings sharing important environmental
(see practice point 1) and depends on the choice of controls and prevalence influences. Therefore, an alternative explanation for familial aggregation of
in the general population. Estimation of genetic relative risk in family stud- disease is that members within a family and members within a racial group
ies, however, does not provide information about the number of genes that share similar environmental influences.
contribute to this risk or the strength of each gene’s contribution.
A second method of assessing the genetic influence in OA is the total
heritability (h2) estimate. This is usually defined as the proportion of
population variance explained by genetic factors.2 It can be calculated by Twin pair studies:
comparing the liability to OA in first-degree relatives to that in more dis-
tant relatives, spouses, or unrelated individuals. Twins are a useful group heritability estimates for OA
matched for upbringing and age, where identical or monozygotic (MZ) The publication in 1996 of the first large-scale OA twin study by Spector
twins share 100 per cent of their genes and non-identical or dizygotic (DZ) et al.11 gave compelling support that the familial clustering was due to a
twins share 50 per cent of their genes. It is assumed that both twins have major genetic contribution to common OA. Using a cohort of 130 MZ and
roughly the same family environment, and that therefore any greater 120 DZ female twin pairs in the age group 48–70 years, a higher intra-class
similarity between the MZ and DZ twins is due to genetic influences.3 correlation among MZ twins compared with DZ twins was observed for
As well as estimating traditional heritability without many of the problems several clinical and radiographic features of OA. Significant differences in
of family studies, comparison of the covariance (or correlation) in OA OA concordance between the MZ and DZ twin pairs remained after control
between the MZ and DZ twins allows separation of the observed pheno- of environmental contributors such as weight, smoking, and oestrogen
typic variance into additive and dominant genetic components and into replacement. The study revealed an h2 between 39–65 per cent, with a con-
common and unique environmental components. This is reviewed in detail cordance rate in the MZ twin pairs of 0.64 compared with 0.38 in the DZ
elsewhere.4 pairs. Incomplete concordance in the MZ twin pairs clearly demonstrated
This chapter reviews evidence of the extent of genetic variation in both an environmental component to disease expression. A twin study focusing
common and rare forms of OA. on radiographic hip OA in female twins was carried out by the same
group.12 An h2 of approximately 50 per cent was determined for disease
defined by joint-space narrowing at the hip joint. A questionnaire based
Family studies: establishing familial twin study from Finland included both male (577 MZ and 1180 DZ) and
female (836 MZ and 1502 DZ) twin pairs.13 Recalled OA at any joint was
risk of OA used as the criterion for disease and an h2 of 44 per cent was obtained for
As early as 60 years ago, in 1941, Stecher5 observed the familial nature of women. Interestingly, this Finnish study detected no genetic component to
idiopathic Heberden’s nodes, which he concluded was explained best by male disease, with a concordance of 0.34 in MZ male twin pairs and 0.38 in
26 4
MZ, monozygotic (identical) twins; DZ, dizygotic (non-identical) twins; TKR, total knee replacement; THR, total hip replacement; JSN, joint-space narrowing.
DZ male twin pairs. This result suggests the possibility that genes play a To understand the mechanism by which OA genetic susceptibility is
more significant role in the development of OA in females. transmitted, Felson et al.16 conducted a segregation analysis of 337 nuclear
families and their adult offspring from the Framingham study. Parent–
offspring and sibling–sibling correlation were determined for primary
Population studies: OA of hand and knee radiographs and were in the range 0.115–0.306. In
segregation analyses, the best-fitting models were mixed models with a
heritability estimates Mendelian mode of inheritance and a residual multi-factorial component
representing either polygenic or environmental factors. The Mendelian
Other population-based studies also support a genetic contribution to
recessive model provided the best fit, although in a subsequent reanalysis
common OA risk (see Table 4.2). Bijkerk and co-workers14 compared the
Spector et al. found that other non-Mendelian models also fitted the data
joint specific frequency of OA between the probands and their siblings
equally.17
enrolled in the Rotterdam study and noted a high level of familial correla-
tion for hand OA (h2 of 0.56), but no correlation for hip or knee OA. The h2
for a score that summed the number of joints affected in the knees,
hips, hands, and spine was 0.78. Hirsch et al.15 studied the familial aggrega- Hereditary disorders causing
tion of OA by determining siblings’ correlations for the disease in a
cohort of patients collected by the Baltimore Longitudinal Study on Ageing.
premature OA
Increased correlation for hand and polyarticular OA demonstrated clear Osteochondrodysplasias, the developmental defects affecting cartilage
familial aggregation of OA. and bone, comprise a large and heterogeneous group of disorders. These
4.1 27
heritable disorders predispose to OA by affecting joint shape, mobility, and Table 4.3 Candidate gene studies in OA
matrix composition. To date the genetic bases for only a few of the over 150
types have been identified.18 An online history of skeletal dysplasias and Gene Number Association result* Author(s)
their responsible genes can be found at www.csmc.edu/genetics/skeldys. COL2A1 n 86 Hull and Pope, 1989
The majority of these Mendelian genetic disorders can be diagnosed COL2A1 n 91 NS Vikkula, 1993
before the onset of adult OA symptoms on the basis of clinical and radio-
logical examinations during childhood and young adulthood (see practice COL2A1 n 21 pairs NS Priestly, 1991
point 2). A proper diagnosis is of practical importance with respect to COL2A1 n 38 pairs NS Loughlin, 1994
genetic and occupational counselling. The skeletal dysplasias are discussed CRTL1 n 38 pairs NS Loughlin, 1994
more fully in the chapter on specific gene defects associated with OA (see
Chapter 4.2). However, even in aggregate, the percentage of common OA CRTM n 38 pairs NS Loughlin, 1994
due to well-characterized genetic syndromes will be low (1 per cent) CRTM n 261 Muelenbelt, 1997
among the osteoarthritic population. The study of heritable arthropathies 2q n 99 pairs Wright, 1996
not only illustrates the significant progress that has been made in the under-
VDR n 351 Keen, 1997
standing of the genetics of these diseases, but also highlights some import-
ant observations that are pertinent in considering the genetic variation VDR n 846 Uitterlinden, 1997
associated with common OA. These include: *NS: not significant.
1. Locus heterogeneity whereby similar clinical phenotypes can result
from mutations in different genes. An example is multiple epiphyseal loci in affected sibling pairs. They tested for linkage of the COL2A1 locus in 48
dysplasia (MED) (see practice point 3). sibling pairs with generalized OA (primary OA in 3 joint groups) but found no
2. Different mutations within the same gene can cause different pheno- evidence of linkage. Two other genes encoding secreted proteins in cartilage
types. For example, different mutations in the COL2A1 gene are asso- link protein (CRTL1) and cartilage matrix protein (CRTM) were also evalu-
ciated with the Stickler syndrome, neonatal achondrogenesis II/ ated for linkage, but neither gene could be substantially associated with OA
hypochondrogenesis, Kniest dysplasia as well as SED. risk. However, the sample size was too small and lacked power. Mustafa et al.32
examined a number of candidates using a cohort of 481 affected sibling pairs
3. Different mutations within the same gene can cause identical phenotypes. ascertained by joint replacement surgery for OA (hip, knee, or hip and knee).
For example, at least 20 different mutations within the COL2A1 gene on Suggestive linkage was obtained to the COL9A1 gene in female affected pairs
chromosome 12 have been associated with the Stickler syndrome.19,20 who were concordant for hip OA, with a LOD score of 2.3.
Meulenbelt et al.33 reported a large Dutch family that has primary OA of
the knees, hands, and the spine, in four generations with disease onset in
Identifying disease genes in the third and fifth decades. The transmittance of OA in this family appears
to be autosomal dominant and ten candidate genes were excluded as the
heritable OA mutant locus, including several that encode structural proteins of the car-
Linkage analysis. The first step for establishing the involvement of a candid- tilage extra-cellular matrix. A genome-wide scan has now linked the OA in
ate gene in heritable OA is the performance of genetic linkage analyses this family to micro-satellite markers on chromosome 2q.34 Roby et al.35
of large kindred populations. Linkage analysis has been utilized widely also excluded several candidate genes in a South African family of Dutch
for linkage studies of type II collagen gene COL2A1 mutations to heritable origin in which severe early-onset hip OA segregates as an autosomal dom-
cartilage diseases. The OA in these pedigrees is best described as secondary inant trait. The group subsequently mapped the disease to chromosome
and related to chondrodysplasia and not the common primary form. 4q35 (LOD score of 5.7).
Linkage analysis, in simple Mendelian disorders, tests for the Genome-wide linkage studies. Scans with the use of affected sibling pairs or
co-segregation of two polymorphic loci. A statistical calculation termed other affected relative pairs is a powerful approach especially if the genetic
the LOD score is a measure of the likelihood that a known normal allele variants under study have a high relative risk for predisposition to OA.
and the mutant allele in question for a disease syndrome co-segregate in a Siblings and other relatives who are concordant for OA because of genetic
family because they are physically close on the same chromosome versus predisposition will inherit their OA-predisposing alleles in common more
the two genes being on different chromosomes and travelling together by than would be expected by chance alone. On the other hand, siblings who
chance alone. For simple Mendelian genetic diseases, a LOD score above 3.0 are discordant for OA would be expected to inherit an OA predisposing
is considered strong statistical evidence of linkage. For complex genetic dis- allele in common less than would be expected by chance alone. Chapman
eases or traits dependent on the number of markers used and information and colleagues36 performed a two-stage genome-wide scan of 481 affected
content, higher LOD scores are required for strong statistical evidence of sibling pairs who were concordant for having undergone joint replacement
linkage. Lander and Kruglyak have reviewed the linkage analysis for com- surgery for primary OA. Analyses of their data suggested a potential OA sus-
plex traits in an excellent review.21 ceptibility region on chromosome 11q13 in the females with hip OA of the
Candidate gene linkage studies. Linkage analysis of affected sibling pairs gives a sibling pairs. Subsequent stratification of this cohort based on gender and
robust analysis especially in addressing uncertainties such as possible environ- site of involvement suggested other potential disease-predisposing genes on
mental con-founders in expression of phenotypes or uncertain inheritance chromosomes 4, 6, and 16.37 In a smaller cohort of 27 Finnish families with
patterns. Few studies have focused on families where OA is the only and pri- hand OA, Leppavuori et al.38 performed a genome-wide scan using
mary disease process without any chondrodysplasia. The other major limita- 302 micro-satellites. Eight regions supported linkage with LOD scores
tion to the studies has been the small numbers of sibling pairs, many with less 1.0 on chromosomes 2q, 4q, 7p, 8q, 9p, 9q, 10p, and 12q. The
than 80 pairs22–29 (See Table 4.3). Genetic studies have shown a positive link- X centromeric region also supported the linkage but at a lower level of
age to COL2A1 in two Finnish families having familial OA with classic clinical significance. In the second stage, additional markers and family members
and radiographic findings.23,30 Mutation analysis of the COL2A1 gene in 45 were genotyped in these chromosomal regions and supported linkage to
unrelated patients with familial OA found only a single putative COL2A1 chromosome 2q. Wright et al.27 genotyped 12 micro-satellite markers in
mutation.31 This result suggests that among patients with common OA, the 44 generalized nodal families in Nottingham, UK. Three of the twelve
incidence of COL2A1 mutations is low, probably even below 2 per cent. markers demonstrated linkage to chromosome 2q. However, the regions of
Loughlin and co-workers25 have investigated candidate genes as susceptibility chromosome 2, predicted to contain nodal OA susceptibility genes by
28 4
Leppavuori and Wright, do not overlap suggesting that this chromosome investigated whether radiographic OA (ROA) is associated with specific
may contain more than one OA susceptibility gene. haplotypes of the COL2A1 gene in a large population-based study. The
Overall linkage analysis of affected sibling pairs has so far identified VNTR allele and the HindIII polymorphism showed significant association
regions of suggestive linkage on chromosomes 2q, 4q, 6, 7p, 11q, 16, and for ROA.
Xcen. Of these, chromosome 2q looks promising as it gave positive results The vitamin D receptor (VDR) has received considerable attention in
in genome screens performed in Oxford, Finland, and Nottingham as well OA. It is a gene implicated in regulating bone mass and density. Keen et al.28
as being linked in the Dutch pedigree. compared the allele frequencies and genotypes of an intragenic TaqI
Association analysis. Another contemporary approach for evaluating candi- dimorphism between females with primary radiographic knee OA and
date genes as risk factors for common OA has employed allelic association female controls. An allele of the Taq1 dimorphism was associated with
studies using case-control cohorts. Several OA association analyses have knee OA and particularly with osteophytes. Furthermore, the TaqI allele
been carried out22–24,26,28,29,39–54 (Table 4.4). Two main underlying was the haplotype associated with ROA at the knee joint in a study from
assumptions are pertinent in this approach. One is that OA risk in appar- Rotterdam.29 The COL2A1 and VDR genes are physically close on chro-
ently unrelated affected individuals is actually due to their inheriting the mosome 12q and one could surmise that an association to COL2A1 may
same OA-predisposing allele from a distant common ancestor. The second in fact be to the VDR gene and vice versa. Both genes alternatively, could
assumption is the prediction of the allele being disease causing. A number harbour susceptibility to OA. Uitterlinden looked at this possibility55 by
of different genes have been studied by tests of allelic association in the typing their subjects for the COL2A1. They have found that both genes
osteoarthritic population. These include the COL2A1 gene, CRTLI and appear to encode susceptibility for knee OA, with COL2A1 associated with
CRTM proteins, vitamin D receptor, oestrogen receptor, insulin-like joint-space narrowing and VDR associated with osteophytes.
growth factor 1, transforming growth factor -1 (TGF-1), and aggrecan. A number of other different genes have been studied by tests of allelic
The first COL2A1 study reported the association of an intragenic dimorph- association including CRTLI and CRTM proteins,26 estrogen receptor,49
ism with radiographic OA in a British cohort.22 Meulenbelt et al.43 insulin-like growth factor 1,50 aggrecan47 without firm conclusions or
CRTM, matrillin 1; CRTL, cartilage link protein; VDR, vitamin D receptor; ER, estrogen receptor; IGF-1, insulin-like growth factor-1; TGF-1, transforming growth factor 1.
4.1 29
confirmation. A Japanese group has found TGF-1 to be related to disc Practice point 1: methods of genetic assessment in OA
degeneration.51 Lumbar disc degeneration has also been associated with
collagen 9 mutations in the Finnish population56 but its relationship to Relative risk to siblings (S)
OA at other sites is unclear. Of the collagen genes, association studies Risk estimates based on the presence of OA in siblings of patients with
have looked at COL1A1,39,40 COL2A1,39,42,57 COL9A1,45 COL11A2.45,46 OA and matched controls is obtained by:
Only COL9A1 and COL11A2 candidate genes reside on a chromosome,
chromosome 6, which has some evidence for linkage in the genome-wide per cent siblings with idiopathic OA
scans. (s)
per cent controls with idiopathic OA
Allelic association studies are challenging to perform, as there may exist
a number of different genetic loci that independently contribute to the risk ◆ Controls in sibling and relative studies ideally resemble siblings
of OA. Also there are the difficulties encountered in selection/stratification
with respect to environmental risk factors but differ from them in
bias and ethnic or phenotypic differences, for instance comparing hip OA
regard to possible genetic determinants
with knee OA, or comparing ROA with end-stage OA. To overcome these
problems, a large number (thousands or tens of thousands) of patients and ◆ Controls should also be representative of the general population
control subjects could be required to identify an individual locus because in terms of their susceptibility to disease
it confers a risk in only a subset or small percentage of the osteoarthritic
population. h2 estimation
◆ A measure of the proportion of total variance of disease in a
population that is due to genetic influences
Defining the OA phenotype ◆ Genetic components include additive genetic effects (the effect
of individual alleles on the trait) and non-additive genetic effects
OA is now recognized as a heterogeneous group of conditions with a wide secondary to genetic dominance (the effect due to non-linear
variety of different pathological processes leading to a common outcome of interaction between alleles at a single locus)
joint destruction and disability. Linkage studies focusing on the end result
of OA, by examining the genetics of severe disease or joint replacement as
Twin pair studies
a categorical variable is a crude and underpowered approach to the prob-
lem. Even using global scores from joint radiographs may be too insensitive. ◆ In the classic twin method, the difference between intra-class
A more useful understanding of the physiology and genetic mechanisms of correlations for MZ twins and those for DZ twins is doubled to
the complex disease may be obtained by studying intermediate phenotypes provide a crude estimate of heritability with the remaining
individually or in combination. These are obtained by dividing OA into population variance attributed to environmental factors
its constituent parts; for example, bone turnover, subchondral bone sclero- h2 2(rMZ rDZ)
sis, osteophyte formation, cartilage turnover and breakdown, cartilage
swelling, hydration, and volume. These intermediate phenotypes may oper-
ate independently or together in clusters determined by pleiotropic genes. Practice point 2: features of simple Mendelian disorders
A number of linkage simulations have suggested that the poor power of
linkage studies can be enhanced upto three-fold by combining the correct ◆ Onset of symptoms at childhood or teenage years
number of correlated phenotypes in analysis. The exact optimum number
◆ Multiple joints affected
and degree of correlation remains to be determined in practice. A common
thread among reported family studies has been that the genetic influences ◆ Unusual joint distribution such as elbow and ankle
on OA appear to be strongest for generalized OA, suggesting some common ◆ Other first degree relatives and family (siblings, offspring, parents)
susceptibility genes. The definition of ‘generalized OA’, however, has no
have similar findings
consensus by clinicians and epidemiologists and in general has weighted
heavily toward hand OA in the clinical studies.11,16 Furthermore, the preval- ◆ Radiographic evidence of skeletal disease at sites other than
ence of disease at any given joint site increases steeply with age, and it is not the symptomatic joint, such as the spine
clear that clustering between sites is greater than would be expected from ◆ There may be a disproportionate short stature or altered
the effects of age. There is a tendency towards polyarticular OA among
body habitus
women aged 45–64 years,58 but there is no single threshold number of joint
sites that can be used to define generalized OA. ◆ A proper diagnosis is of practical importance with respect to
genetic and occupational counselling
25. Loughlin, J., Irven, C., Fergusson, C., and Sykes B. (1994). Sibling pair
References analysis shows no linkage of generalized osteoarthritis to the loci encoding
(An asterisk denotes recommended reading.) type II collagen, cartilage link protein or cartilage matrix protein. Br J
1. Cooper, C., McAlindon, T., Snow, S., et al. (1994). Mechanical and constitu- Rheumatol 33(12):1103–6.
tional risk factors for symptomatic knee osteoarthritis: differences between 26. Meulenbelt, I., Bijkerk, C., De Wildt, S.C., et al. (1997). Investigation of the
medial tibiofemoral and patellofemoral disease. J Rheumatol 21(2):307–13. association of the CRTM and CRTL1 genes with radiographically evident
2. Reich, T., James, J.W., and Morris, C.A. (1972). The use of multiple thresh- osteoarthritis in subjects from the Rotterdam study [see comments].
olds in determining the mode of transmission of semi-continuous traits. Arthritis Rheum 40(10):1760–5.
Ann Hum Genet 36(2):163–84. 27. Wright, G.D., Hughes, A.E., Regan, M., and Doherty, M. (1996).
3. Spector, T.D., Snieder, H., and MacGregor, A.J. (2000). Advances in twin Association of two loci on chromosome 2q with nodal osteoarthritis. Ann
and sib-pair analysis (1st ed.). Oxford: Oxford University Press. Rheum Dis 55(5):317–9.
4. *MacGregor, A.J., Spector, T.D. (1999). Twins and the genetic architecture of 28. Keen, R.W., Hart, D.J., Lanchbury, J.S., and Spector, T.D. (1997).
osteoarthritis. Rheumatology 38(7):583–8. Association of early osteoarthritis of the knee with a Taq I polymorphism of
A good review of the use of twin pairs in genetic studies with emphasis on OA. the vitamin D receptor gene. Arthritis Rheum 40(8):1444–9.
5. Stecher, R.M. (1941). Heberden’s nodes. Hereditary in hypertrophic arth- 29. Uitterlinden, A.G., Burger, H., Huang, Q., et al. (1997). Vitamin D receptor
ritis of finger joints. Am J Med Sci 201:801–9. genotype is associated with radiographic osteoarthritis at the knee. J Clin
6. Kellgren, J.H., Lawrence, J.S., and Bier, F. (1963). Genetic factors in general- Invest 100(2):259–63.
ized osteoarthrosis. Ann Rheum Dis 22:237–55. 30. Palotie, A., Vaisanen, P., Ott, J., et al. (1989). Predisposition to familial
7. Lawrence, J.S. and Moore, J. (1952). Generalized osteoarthritis and osteoarthrosis linked to type II collagen gene. Lancet 1(8644):924–7.
Heberden’s nodes. Br Med J 1:181–7. 31. Ritvaniemi, P., Korkko, J., Bonaventure, J., et al. (1995). Identification of
8. Lindberg, H. (1986). Prevalence of primary coxarthrosis in siblings of COL2A1 gene mutations in patients with chondrodysplasias and familial
patients with primary coxarthrosis. Clin Orthop 203:273–5. osteoarthritis. Arthritis Rheum 38(7):999–1004.
9. Chitnavis, J., Sinsheimer, J.S., Clipsham, K., et al. (1997). Genetic influences 32. Mustafa, Z., Chapman, K., Irven, C., et al. (2000). Linkage analysis of candid-
in end-stage osteoarthritis. Sibling risks of hip and knee replacement for ate genes as susceptibility loci for osteoarthritis-suggestive linkage of
idiopathic osteoarthritis. J Bone Joint Surg Br 79(4):660–4. COL9A1 to female hip osteoarthritis. Rheumatology 39(3):299–306.
10. Lanyon, P., Muir, K., Doherty, S., and Doherty, M. (2000). Assessment of 33. Meulenbelt, I., Bijkerk, C., Breedveld, F.C., and Slagboom, P.E. (1997).
a genetic contribution to osteoarthritis of the hip: sibling study. Br Med J Genetic linkage analysis of 14 candidate gene loci in a family with autosomal
321:1179–83. dominant osteoarthritis without dysplasia. J Med Genet 34(12):1024–7.
11. Spector, T.D., Cicuttini, F., Baker, J., Loughlin, J., and Hart, D. (1996). Genetic 34. Loughlin, J. (2001). Genetic epidemiology of primary osteoarthritis. Curr
influences on osteoarthritis in women: a twin study. Br Med J 312:940–3. Opin Rheumatol 13(2):111–16.
12. MacGregor, A.J., Antoniades, L., Matson, M., Andrew, T., and Spector, T.D. 35. Roby, P., Eyre, S., Worthington, J., et al. (1999). Autosomal dominant
(2000). The genetic contribution to radiographic hip osteoarthritis in (Beukes) premature degenerative osteoarthropathy of the hip joint maps to
women: results of a classic twin study. Arthritis Rheum 43(11):2410–16. an 11-cM region on chromosome 4q35. Am J Hum Genet 64(3):904–8.
13. Kaprio, J., Kujala, U.M., Peltonen, L., and Koskenvuo, M. (1996). Genetic lia- 36. *Chapman, K., Mustafa, Z., Irven, C., et al. (1999). Osteoarthritis-
bility to osteoarthritis may be greater in women than men. Br Med J 313:232. susceptibility locus on chromosome 11q, detected by linkage. Am J Hum
Genet 65(1):167–74.
14. Bijkerk, C., Houwing-Duistermaat, J.J., Valkenburg, H.A., et al. (1999).
The first published genome scan for OA susceptibility locus.
Heritabilities of radiologic osteoarthritis in peripheral joints and of disc
degeneration of the spine. Arthritis Rheum 42(8):1729–35. 37. *Loughlin, J., Mustafa, Z., Irven, C., et al. (1999). Stratification analysis
of an osteoarthritis genome screen-suggestive linkage to chromosomes 4, 6,
15. Hirsch, R., Lethbridge-Cejku, M., Hanson, R., et al. (1998). Familial aggrega-
and 16. Am J Hum Genet 65(6):1795–8.
tion of osteoarthritis: data from the Baltimore Longitudinal Study on Aging.
Additional loci detected by stratification of a genome scan.
Arthritis Rheum 41(7):1227–32.
38. Leppavuori, J., Kujala, U., Kinnunen, J., et al. (1999). Genome scan for pre-
16. Felson, D.T., Couropmitree, N.N., Chaisson, C.E., et al. (1998). Evidence for
disposing loci for distal interphalangeal joint osteoarthritis: evidence for a
a Mendelian gene in a segregation analysis of generalized radiographic
locus on 2q. Am J Hum Genet 65(4):1060–7.
osteoarthritis: the Framingham Study. Arthritis Rheum 41(6):1064–71.
39. Aerssens, J., Dequeker, J., Peeters, J., Breemans, S., and Boonen, S. (1998).
17. Spector, T.D., Snieder, H., and Keen, R. (1999). Interpreting the results of a
Lack of association between osteoarthritis of the hip and gene poly-
segregation analysis of generalized radiographic osteoarthritis: comment on
morphisms of VDR, COL1A1, and COL2A1 in postmenopausal women.
the article by Felson et al. Arthritis Rheum 42(5):1068–70.
Arthritis Rheum 41(11):1946–50.
18. International nomenclature and classification of the osteochondrodysplasias
40. Loughlin, J., Sinsheimer, J.S., Mustafa, Z., et al. (2000). Association analysis
(1997). (International Working Group on Constitutional Diseases of Bone
of the vitamin D receptor gene, the type I collagen gene COL1A1, and the
1998.) Am J Med Genet 79(5):376–82.
estrogen receptor gene in idiopathic osteoarthritis. J Rheumatol 27(3):
19. Annunen, S., Korkko, J., Czarny, M., et al. (1999). Splicing mutations of
779–84.
54-bp exons in the COL11A1 gene cause the Marshall syndrome, but other
41. Knowlton, R.G., Katzenstein, P.L., Moskowitz, R.W., et al. (1990). Genetic
mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum
linkage of a polymorphism in the type II procollagen gene (COL2A1) to prim-
Genet 65(4):974–83.
ary osteoarthritis associated with mild chondrodysplasia. N Engl J Med
20. Snead, M.P. and Yates, J.R. (1999). Clinical and molecular genetics of
322(8):526–30.
Stickler syndrome. J Med Genet 36(5):353–9.
42. Loughlin, J., Irven, C., Athanasou, N., Carr, A., and Sykes, B. (1995).
21. Lander, E. and Kruglyak, L. (1995). Genetic dissection of complex traits:
Differential allelic expression of the type II collagen gene (COL2A1) in
guidelines for interpreting and reporting linkage results. Nat Genet
osteoarthritic cartilage. Am J Hum Genet 56(5):1186–93.
11(3):241–7.
43. Meulenbelt, I., Bijkerk, C., De Wildt, S.C., et al. (1999). Haplotype analysis
22. Hull, R. and Pope, F.M. (1989). Osteoarthritis and cartilage collagen genes.
of three polymorphisms of the COL2A1 gene and associations with general-
Lancet 1(8650):1337–8.
ized radiological osteoarthritis. Ann Hum Genet 63(Pt 5):393–400.
23. Vikkula, M., Palotie, A., and Ritvaniemi, P., et al. (1993). Early-onset
44. *Uitterlinden, A.G., Burger, H., van Duijn, C.M., et al. (2000). Adjacent
osteoarthritis linked to the type II procollagen gene. Detailed clinical pheno-
genes, for COL2A1 and the vitamin D receptor, are associated with separate
type and further analyses of the gene. Arthritis Rheum 36(3):401–9.
features of radiographic osteoarthritis of the knee. Arthritis Rheum
24. Priestley, L., Fergusson, C., Ogilvie, D., et al. (1991). A limited association of 43(7):1456–64.
generalized osteoarthritis with alleles at the type II collagen locus: COL2A1. Determines possible linkage disequilibrium between VDR and COL2A1
Br J Rheumatol 30(4):272–5. genes.
4.1 31
45. van Duijn, C.M., Bijkerk, C., Houwing-Duistermaat, J.J., et al. (1998). 52. Jones, G., White, C., Sambrook, P., Eisman, J. (1998). Allelic variation in the
A population based study of the genetics of osteoarthritis [abstract]. Am J vitamin D receptor, lifestyle factors and lumbar spinal degenerative disease.
Hum Genet 63(Suppl.):1282. Ann Rheum Dis 57(2):94–9.
46. Leppavuori, J.K., Pastinen, T., Kujala, U. et al. (2000). Array-based candidate 53. Videman, T., Leppavuori, J., Kaprio, J., et al. (1998). Intragenic poly-
gene analysis identify COL11A2 on 6p21.3 as predisposing locus for distal morphisms of the vitamin D receptor gene associated with intervertebral
interphalangeal joint osteoarthritis [abstract]. Am J Hum Genet 67(Suppl.):125. disc degeneration. Spine 23(23):2477–85.
47. Horton, W.E. Jr, Lethbridge-Cejku, M., Hochberg, M.C., et al. (1998). An 54. Huang, J., Ushiyama, T., Inoue, K., Kawasaki, T., and Hukuda, S. (2000).
association between an aggrecan polymorphic allele and bilateral hand Vitamin D receptor gene polymorphisms and osteoarthritis of the hand, hip,
osteoarthritis in elderly white men: data from the Baltimore Longitudinal and knee: a case-control study in Japan. Rheumatology 39(1):79–84.
Study of Aging (BLSA). Osteoarthritis Cart 6(4):245–51. 55. Uitterlinden, A.G., Burger, H., van Duijn, C.M., et al. (2000). Adjacent
48. Kawaguchi, Y., Osada, R., Kanamori, M., et al. (1999). Association between genes, for COL2A1 and the vitamin D receptor, are associated with separate
an aggrecan gene polymorphism and lumbar disc degeneration. Spine features of radiographic osteoarthritis of the knee. Arthritis Rheum
24(23):2456–60. 43(7):1456–64.
49. Ushiyama, T., Ueyama, H., Inoue, K., Nishioka, J., Ohkubo, I., and 56. Paassilta, P., Lohiniva, J., Goring, H.H., et al. (2001). Identification of
Hukuda, S. (1998). Estrogen receptor gene polymorphism and generalized a novel common genetic risk factor for lumbar disk disease. JAMA
osteoarthritis. J Rheumatol 25(1):134–7. 285(14):1843–9.
50. Meulenbelt, I., Bijkerk, C., Miedema, H.S., et al. (1998). A genetic associ- 57. Vikkula, M., Nissila, M., Hirvensalo, E., et al. (1993). Multiallelic poly-
ation study of the IGF-1 gene and radiological osteoarthritis in a population- morphism of the cartilage collagen gene: no association with osteo-
based cohort study (the Rotterdam Study). Ann Rheum Dis 57(6):371–4. arthrosis. Ann Rheum Dis 52(10):762–4.
51. Yamada, Y., Okuizumi, H., Miyauchi, A., Takagi, Y., Ikeda, K., Harada, A. 58. Cooper, C., Egger, P., Coggon, D., et al. (1996). Generalized osteoarthritis
(2000). Association of transforming growth factor beta1 genotype with in women: pattern of joint involvement and approaches to definition for
spinal osteophytosis in Japanese women. Arthritis Rheum 43 (2):452–60. epidemiological studies. J Rheumatol 23(11):1938–42.
This page intentionally left blank
4.2 Specific gene defects associated with
osteoarthritis
Thorvaldur Ingvarsson and Stefan Einar Stefansson
The recent publication of a first draft of the human genomic sequence will
facilitate the search for OA genes but the obstacles remain significant. For
The study of candidate genes for OA by
example, the identification of positional candidates still depends on association analysis
uncovering evidence of linkage between a chromosomal region and an OA
A candidate gene is defined as a gene whose protein product, based on its
phenotype. Once a chromosomal region has been found to link to OA it will
biological activity, can plausibly be assumed to influence the disease
be necessary to find a gene in the linked region and for this it will in many
(phenotype) under consideration. The candidate gene can be directly
cases be necessary to narrow the region down, by applying additional
screened for mutations in the affected family or individuals. The main
marker sets, to a more manageable size for DNA sequencing or other muta-
problem with this approach is that the number of these proteins is already
tion detection techniques. However, it is not sufficient merely to show an
large, and as more is learned about cartilage and bone biology the list of
association between a variant in a candidate gene and a phenotype, since
potential candidate genes keeps growing. The chances of a ‘lucky hit’ would
such an association may merely reflect linkage disequilibrium. The variant,
seem to be remote. Indeed studies of candidate genes have been disappoint-
such as a missense mutation, must also be shown to alter the biological
ing, with the exception of some of the chondrodysplasia families.
function of a protein in animal models or a tissue such as cartilage that
Most of the association analyses for OA, which have targeted candidate
relates to OA. For putative mutations in regulatory regions this chain of evi-
genes, have tended to be genes encoding structural proteins of the
dence becomes even more crucial. Current developments in molecular biol-
extracellular matrix of cartilage and bone or genes implicated in the regu-
ogy such as micro-array chips now allow the simultaneous large-scale
lation of bone density.
identification of thousands of genes with differential expression in disease.
Some examples of known mutations in candidate genes follow (see
This will enhance our ability to identify candidate molecules and processes
Table 4.5 for more information).
that are relevant to OA pathology.
Multiple pathogenetic mechanisms are implicated in the development
of OA. Continued studies of the kind outlined here will clarify the complex
genetic background of OA and identify genetic variation associated with
COL2A1
the disease. In addition to improving our understanding of the pathogen- A large number of mutations (over 100) have been reported in the
esis of OA and identifying new molecular targets for treatment, this know- COL2A1 gene on chromosome 12, which codes for II collagen.3 The clinical
ledge will also allow a better insight into the interactions between the genetic phenotypes have ranged widely in severity from the achondrogenesis
background and the environmental factors that initiate and drive OA. type II and hypochondrogenesis at the severe end of the spectrum to very
mild spondyloepiphyseal dysplasia (SED) with precocious OA, often called
late onset SED. Further phenotypes have included early onset premature
generalized OA (PGOA),4,5 families with crystal deposition disease pheno-
Is OA subject to major gene effects? types of intermediate severity,6 SED-congenita, and Kniest dysplasia.
Mutations have also been described in Stickler dysplasia, in which skeletal
Given that genetic factors may play a major role in the etiology of OA, the
phenotype is typical with OA rather than short stature, including eye
question arises whether these influences are exerted by one or a few ‘major
and inner ear abnormalities. See Table 4.5 and Refs 2 and 13 for further
genes’ each with a relatively large effect, such as the COL2A1 gene, or by a
details.
large number of ‘polygenes’, each with a relatively minor effect. Presumably,
in the monogenic form of OA the genes would be easier to identify and
could have greater relevance to public health. Complex segregation analysis
can be used to study the mode of inheritance of a trait and in particular to
COL11A2
infer whether the distribution of the trait within pedigrees is compatible Mutations have been described in the COL11A2 gene, which encode the
with the action of a major gene. This was done by Felson and co-workers in alpha-2 chain of type XI collagen3,7 in families with Stickler syndromes
1998,1 concluding that in generalized OA (in this study hand and knee OA) presenting mild SED, premature OA and sensorineural hearing loss, but
there was evidence to support a significant genetic contribution, with evid- lacking the eye involvement.
ence for a major recessive gene and a multi-factorial component, repres-
enting either polygenic or environmental factors. However, the evidence is
not yet conclusive that ‘common OA’ is influenced by major genes.2 On the COL9A1
contrary, several susceptible loci for OA have been suggested and each of Several mutations have been found in the gene for type IX collagen,7 all
them is thought to include a possible gene for OA. This could support the associated with Schmid metaphyseal chondrodysplasia, which is a relatively
notion that the inherited OA is a polygenic disease. mild chondrodysplasia.
34 4
Table 4.5 Examples of known genes associated with OA mutations, their chromosomal location and the respective protein
Gene/locus Chromosome Gene product function Clinical phenotype Known mutations Reference Protein
COL11A1 1p21 Extracellular matrix protein Knee, hip, hand No 3,7 Alpha-1-chain type XI
collagen
COL11A2 6p21.3 Extracellular matrix protein Stickler dysplasia-SED Yes 3 Alpha-2-chain type XI
late onset, knee, collagen
hip, hand
COL2A1 12q13-q14 Extracellular matrix protein Achondrogenesis Yes 2 Alpha-1-chain type II
Hypochondrogenesis hundreds collagen
SED congenita
SED late onset
Kniest dysplasia
Stickler dysplasia
COL9A1 6q12-q13 Extracellular matrix protein Knee, hip, hand Yes 4 Alpha-1-chain type IX
collagen
COL9A2 1p32 Extracellular matrix protein Multiple epiphyseal Yes 3 Alpha-2-chain type IX
dysplasia collagen
COL10A1 6p Extracellular matrix protein Schmid metaphyseal Yes 3 Alpha-1-chain type X
hypertrophic cartilage chondrodysplasia several collagen
COMP 19p13.1 Extracellular matrix protein Multiple epiphyseal Yes 3 cartilage oligomeric matrix
dysplasia (Fairbanks) many protein
Pseudoachondroplasia
FGFR3 4p16.3 Tyrosine kinase transmembrane Thanotophoric dysplasia Yes 3,65–66
receptor for FGFs Achondrodysplasia many
Hypochondrodysplasia
PTHrPR 11p15.3 G-protein transmembrane Jansen metaphyseal Yes 3 G-protein
receptor for PTH and PTHrP chondrodysplasia
CRTL1 5q13-14.1 Cartilage link protein Hip or knee 53 Cartilage link protein
DTDST 5q31-q34 Transmembrane sulfate Achondrogenesis type IB Yes 3 diastrophic dysplasia sulfate
transporter Atelosteogenesis type II several transporter
Diastrophic dysplasia
VDR 12q13-q14 Vitamin D-receptor Hip, knee, hand, spine Unknown loci 9,10,54–56
CPDD, calcium pyrophosphate deposition disease; GOA, generalized osteoarthritis; OA, osteoarthritis; COL, collagen; ER, estrogen receptor; GOA, generalized osteoarthritis;
OA, osteoarthritis. IGF, insulin-like growth factor; TGF, transforming growth factor; JS, joint space.
36 4
identify an association with the genes for collagen types II and VI, chon- or both, for primary OA, Heberden’s nodes were noted in 38.5 per cent of
droitin sulfate, proteoglycan core protein, and cartilage link protein. the affected individuals. Using a genome-wide scan, a locus associating
Subsequent studies identified mutations in the gene encoding COMP,38,39 with OA in women was identified on chromosome 11q with a LOD score
in the COL9A2 gene,40,41 and lately in the MATN3 gene on chromosome 2.8 between 2 and 3. The authors suggested that a female-specific susceptibil-
It is likely that additional and different loci will be identified, since other ity gene for primary OA was present on chromosome 11q.45 Further
families with this phenotype have been shown to lack genetic linkage with reports on genome-wide scans have indicated the existence of multiple sus-
either COMP or COL9A2.42 ceptibility loci for OA by stratifying the same material by gender and joint.
It has even been shown that mutations in MED can in some cases be Thus, linkage to loci on chromosomes 2, 4, 6, and 16 was proposed.2,46
joint specific. The type of MED with predominant involvement of the
capital femoral epiphyses can have mutations in the COMP gene,43 and Chromosome 2
those patients with predominant involvement of knees with relative hip
sparing can have COL9A2 or COL9A3 mutations.43 This suggests that A suggestion of linkage was based on a LOD score of 1.22 that increased to
mutations can be joint specific with regard to phenotypic expression. 2.19 in hip patients, and it was stated that this suggestive linkage was greater
However, we do not as yet know if there are corresponding differences in for male hip patients. The proposed region 2q31 is at a similar location
the developmental or spatial expression patterns of these genes between described in nodal OA47 and near a locus, which was described for DIP
different joints. Table 4.7 lists examples of known genes and mutations OA.48 It appears possible that chromosome 2q contains at least one suscept-
associated with OA. ibility locus for OA.
----------PERSIA: End--------
----------PERU: Start--------
PERU: A. D. 1899-1908.
Outline of History.
Dr. Pardo’s Cabinet was formed of some of the most capable men
in the country, prominent among whom was the minister of
Finance, Señor Leguia, to whose work is largely due the
improved financial situation. At the present time—1908—the
best elements of Peru are in the ascendant."
G. Reginald Enock,
Peru: Its Former, and Present Civilization,
History and Existing Conditions,
chapter 9 (Scribner’s Sons, New York).
PERU: A. D. 1901.
Broad Treaty of Arbitration with Bolivia.
PERU: A. D. 1901-1906.
Participation in Second and Third International Conferences
of American Republics.
PERU: A. D. 1903-1909.
Boundary disputes in the Acre region with Bolivia and Brazil.
PERU: A. D. 1905.
Arbitration Treaties with Colombia and Ecuador.
PERU: A. D. 1906.
Decree for the Encouragement of Immigration.
PERU: A. D. 1907.
Diplomatic Relations with Chile reëstablished.
The Tacna and Arica questions remaining open.
----------PERU: End--------
{492}
PETROLEUM:
The Supply and the Waste in the United States.
PHILADELPHIA: A. D. 1905.
A Spasm of Municipal Reform.
PHILADELPHIA: A. D. 1909.
Defeat of Reform.
See (in this Volume)
MUNICIPAL GOVERNMENT.
PHILIPPINE ISLANDS:
Gains to Spain from their Loss.
{493}
"The policy of the commission in its provincial appointments
has been, where possible, to appoint Filipinos as governors
and Americans as treasurers and supervisors. The provincial
secretary and the provincial fiscal appointed have uniformly
been Filipinos. It will be observed that this makes a majority
of the provincial board American. The commission has, in
several instances, appointed to provincial offices former
insurgent generals who have been of especial aid in bringing
about peace, and in so doing it has generally acted on the
earnest recommendation of the commanding officer of the
district or province. We believe the appointments made have
had a good effect and the appointees have been anxious to do
their duty. …
{494}
"By an act passed June 17, 1902, Number 419, the Commission
organized the province of Samar, and established civil
government there. In April of 1902, General Malvar surrendered
with all his forces in Batangas, and by act passed June 23,
1902, the Commission restored civil government to that
province to take effect July 4, 1902. By act Number 424,
enacted July 1, 1902, the province of Laguna was organized
into a civil government. This completed the organization of
all the provinces in which insurrection had been rife during
the latter part of 1901, except Mindoro. There were, in
addition, certain tracts of territory occupied by Christian
Filipinos that had not received civil government, either
because of the remoteness of the territory or the scarcity of
population." The report then details the measures by which
civil government was given to these tracts of territory, and
proceeds:
"The cholera has swept over these islands with fatal effect,
so that the total loss will probably reach 100,000 deaths.
Whole villages have been depopulated and the necessary
sanitary restrictions to avoid its spread have interfered with
agriculture, with intercommunication, and with all business.
The ravages of war have left many destitute, and a guerrilla
life has taken away from many all habits of industry. With no
means of carrying on agriculture, which is the only occupation
of these islands, the temptation to the less responsible of
the former insurgents after surrender to prey upon their
neighbors and live by robbery and rapine has been very great.
The bane of Philippine civilization in the past was ladronism,
and the present conditions are most favorable for its growth
and maintenance. … Many who were proscribed for political
offences in the Spanish times had no refuge but the mountains,
and being in the mountains conducted a free robber life, and
about them gathered legions not unlike those of the Robin Hood
days of England, so that they attracted frequently the
sympathy of the common people. In the Spanish days it was
common for the large estate owners, including the friars, to
pay tribute to neighboring ladrones. Every Tagalog province
had its band of ladrones, and frequently each town had its
recognized ladrone whom it protected and through whom it
negotiated for immunity. …
{495}
{496}
{497}
"The act of Congress requires that delegates to the assembly
shall be qualified electors of the election district in which
they may be chosen, 25 years of age, and owing allegiance to
the United States. The act of Congress prescribes that the
qualifications of electors shall be the same as those
prescribed for electors in municipal elections under laws in
force at the time of the passage of the Congressional
enactment. As the municipal election laws in force at the time
of the passage of the act of Congress have undergone some
change in regard to the qualifications of electors, the
strange anomaly is presented of having certain
qualifications exacted from municipal and provincial officials
which are not required for delegates to the assembly. One of
the results is that felons, victims of the opium habit, and
persons convicted in the court of first instance for crimes
involving moral turpitude, but whose cases are pending on
appeal, are not eligible for election to any provincial or
municipal office, but may become delegates to the assembly.
"Some six months before the elections, there sprung from the
ashes of the Federal Party a party which, rejecting the
statehood idea, declared itself in favor of making the
Philippines an independent nation by gradual and progressive
acquisition of governmental control until the people should
become fitted by education and practice under American
sovereignty to enjoy and maintain their complete independence.
It was called the Partido Nacionalista Progresista. It is
generally known as the Progresista Party. …
{498}
"The total vote registered and cast did not exceed 104,000,
although in previous gubernatorial elections the total vote
had reached nearly 150,000. The high vote at the latter
elections may be partly explained by the fact that at the same
elections town officers were elected, and the personal
interest of many candidates drew out a larger number of
electors. But the falling off was also in part due, doubtless,
to the timidity of conservative voters, who, because of the
heat of the campaign, preferred to avoid taking sides. This is
not a permanent condition, however, and I doubt not that the
meeting of the assembly and the evident importance of its
functions when actually performed will develop a much greater
popular interest in it, and the total vote will be largely
increased at the next election.
"I opened the assembly in your name. The roll of the members
returned on the face of the record was called. An appropriate
oath was administered to all the members and the assembly
organized by selecting Señor Sergio Osmeña as its speaker or
presiding officer. Señor Osmeña has been one of the most
efficient fiscals, or prosecuting attorneys, in the Islands,
having conducted the government prosecutions in the largest
province of the Islands, the province and Island of Cebu. He
was subsequently elected governor, and by his own activity in
going into every part of the island, he succeeded in enlisting
the assistance of all the people in suppressing ladronism,
which had been rife in the mountains of Cebu for thirty or
forty years, so that to-day there is absolute peace and
tranquillity throughout the island. He is a young man, not 30,
but of great ability, shrewdness, high ideals, and yet very
practical in his methods of dealing with men and things. The
assembly could have done nothing which indicated its good
sense so strongly as the selection of Senor Osmeña as its
presiding officer. …